Continuous positive airway pressure

CPAP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^WX722 1 out of 7 registries used, show all original rules.	10126
4. Check minimum number of events None	10126
5. Include endpoints None	10126
6. Filter based on genotype QC (FinnGen only)	9817

Control definitions (FinnGen only)

Control exclude: ILD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	CPAP
CONTROL_EXCLUDE	ILD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^WX722
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Continuous positive airway pressure based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	62273	23857	38134
Only index persons	45606	16596	29010
Unadjusted period prevalence (%)
Whole population	0.92	0.68	1.07
Only index persons	0.93	0.61	1.11
Median age at first event (years)
Whole population	57.66	59.07	56.68
Only index persons	62.08	64.84	60.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9817	3800	6017
Unadjusted period prevalence (%)	2.21	1.35	2.76
Median age at first event (years)	63.23	62.21	63.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9947: Matched controls
83761

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A12BA01

ATC

potassium chloride; oral

8.8

322.1

449

450

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

321.0

2805

11399

I20.90

ICD-10 Finland

Angina pectoris, unspecified

728.8

320.0

335

R53

ICD-10 Finland

Malaise and fatigue

2.8

319.4

2095

7389

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.4

318.5

912

1893

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

318.4

4126

19921

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.9

316.4

1087

2586

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.9

316.3

1906

6423

C01BC04

ATC

flecainide; systemic

47.0

315.9

213

R60.0

ICD-10 Finland

Localized oedema

3.4

312.6

1318

3599

TFP34

NOMESCO Finland

Electrophysiological investigation

86.7

312.5

192

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.7

311.1

549

729

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.2

309.9

1439

4172

R01AD09

ATC

mometasone; nasal

2.2

309.3

4680

23996

TK800

NOMESCO Finland

Hemodialysis

12.1

308.2

343

246

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

95.1

307.7

625

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

9.1

307.7

1135

1165

GD1LA

NOMESCO Finland

39.9

307.7

227

XG466

NOMESCO Finland

Sleep oxymetry

39.6

307.7

1450

359

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

42.6

307.7

649

137

R06.0

ICD-10 Finland

Dyspnoea

5.3

307.7

3324

7227

205

Kela drug reimbursment

Chronic hypertension

4.0

307.7

2894

7805

A10BK03

ATC

empagliflozin; oral

382.8

307.7

1093

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

12.9

307.7

494

338

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

11.5

307.7

2920

2925

R4110

NOMESCO Finland

Physiotherapy

3.3

307.7

3616

12354

Z01.8

ICD-10 Finland

Other specified special examinations

3.1

307.7

2463

8097

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

60.0

307.7

659

C10AX09

ATC

ezetimibe; oral

4.0

307.7

1287

2994

103

Kela drug reimbursment

Diabetes, insulin-treated

2113.2

307.7

3551

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.2

307.7

1591

4740

I50.0

ICD-10 Finland

Congestive heart failure

52.7

307.7

1203

218

A10BK01

ATC

dapagliflozin; oral

152.3

307.7

905

C01BD01

ATC

amiodarone; systemic

778.5

307.7

357

N06AX21

ATC

duloxetine; oral

4.0

307.7

1086

2473

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3076.6

307.7

361

A10AE05

ATC

insulin detemir; parenteral

1135.5

307.7

512

A10AB01

ATC

insulin (human); parenteral

123.4

307.7

243

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

34.2

307.7

376

C03DA01

ATC

spironolactone; oral

10.1

307.7

1685

1660

C03CA01

ATC

furosemide; systemic

9.4

307.7

4048

5683

A46

ICD-10 Finland

Erysipelas

3.5

307.7

1674

4636

R03BB04

ATC

tiotropium bromide; inhalant

5.8

307.7

1441

2371

M04AA01

ATC

allopurinol; systemic

5.4

307.7

1704

3092

A02BC02

ATC

pantoprazole; systemic

2.9

307.7

6945

37177

WX892

NOMESCO Finland

Monitored bed care

13.6

307.7

1449

1035

I49.3

ICD-10 Finland

Ventricular premature depolarization

8.1

307.7

540

593

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

60.9

307.7

554

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

307.7

457

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

98.2

307.7

644

I49.5

ICD-10 Finland

Sick sinus syndrome

145.7

307.7

302

RK320, ,

NOMESCO Finland

39.9

307.7

422

ZXD05

NOMESCO Finland

Urgent procedure

3.2

307.7

3212

10775

A10BD07

ATC

metformin and sitagliptin; systemic

1285.4

307.7

432

P06

ICPC

Sleep disturbance

4.1

307.7

1436

3295

H02AB07

ATC

prednisone; oral

3.1

307.7

1698

5284

J96.1

ICD-10 Finland

Chronic respiratory failure

926.8

307.7

422

E66.8

ICD-10 Finland

Other obesity

78.3

307.7

1012

121

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

9.9

307.7

712

646

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

122.5

307.7

1089

N06AB04

ATC

citalopram; systemic

4.0

307.7

2112

5258

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

14.6

307.7

350

208

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.1

307.7

652

953

R07.4

ICD-10 Finland

Chest pain, unspecified

3.7

307.7

2773

7994

Z3229

NOMESCO Finland

Other healthcare associate professional

4.5

307.7

1269

2641

201

Kela drug reimbursment

Chronic cardiac insufficiency

28.5

307.7

554

173

C09AA02

ATC

enalapril; systemic

3.0

307.7

1896

6105

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1211.9

307.7

411

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

10.7

307.7

601

501

R03AC02

ATC

salbutamol; inhalant

2.6

307.7

5551

27479

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

26.4

307.7

254

Z3231

NOMESCO Finland

Registered nurse

4.0

307.7

3748

11032

L28

ICPC

Limited function/disability (L)

3.6

307.7

1987

5433

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

10.5

307.7

504

423

E11

ICD-10 Finland

Type 2 diabetes mellitus

42.3

307.7

2141

539

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

63.9

307.7

230

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

7.2

307.7

955

1216

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

9.4

307.7

475

444

A10AE04

ATC

insulin glargine; parenteral

498.5

307.7

1198

N05AH04

ATC

quetiapine; oral

4.1

307.7

1432

3291

A10BB12

ATC

glimepiride; oral

402.9

307.7

752

I50.1

ICD-10 Finland

Left ventricular failure

54.3

307.7

669

111

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.2

307.7

3222

8532

I10

ICD-10 Finland

Essential (primary) hypertension

4.2

307.7

6850

28977

I50

ICD-10 Finland

Heart failure

45.2

307.7

466

AA1AD

NOMESCO Finland

CT of head and brain

4.0

307.7

2820

7483

Angiography of the heart and coronary arteries

60.8

307.7

540

I48.1

ICD-10 Finland

Persistent atrial fibrillation

171.2

307.7

334

J96.0

ICD-10 Finland

Acute respiratory failure

33.7

307.7

299

XF402

NOMESCO Finland

ECG with work load test

8.3

307.7

1338

1533

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

44.2

307.7

231

I50.9

ICD-10 Finland

Heart failure, unspecified

30.1

307.7

2136

753

SPAT1262

SPAT

Handing over of treatment supplies

11.0

307.7

2342

2291

215

Kela drug reimbursment

Diabetes, non-insulin-treated

9957.4

307.7

3258

TFP20

NOMESCO Finland

Cardiodefibrillation

340.6

307.7

817

K78

ICPC

Atrial fibrillation/flutter

35.4

307.7

705

180

N06AX12

ATC

bupropion; oral

7.4

307.7

641

775

C07AB07

ATC

bisoprolol; oral

7.5

307.7

5484

11837

C10AA05

ATC

atorvastatin; oral

3.4

307.7

4341

15517

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.7

307.7

2792

6371

E66.00

ICD-10 Finland

Metabolic syndrome

27.7

307.7

1093

372

I25

ICD-10 Finland

Chronic ischaemic heart disease

67.3

307.7

458

WX872

NOMESCO Finland

Intensive care

19.8

307.7

727

332

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.8

307.7

1608

4004

N05BA04

ATC

oxazepam; oral

2.8

307.7

2248

7921

I48.2

ICD-10 Finland

Chronic atrial fibrillation

454.2

307.7

365

I35.0

ICD-10 Finland

Aortic (valve) stenosis

7.4

307.7

551

659

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.4

307.7

1058

2214

A10BH05

ATC

linagliptin; oral

1074.4

307.7

600

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

952

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

307.7

1284

3254

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

4.5

307.7

1397

2947

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.0

307.7

1423

2281

G47.3

ICD-10 Finland

Sleep apnoea

30.9

307.7

7564

7805

F32.9

ICD-10 Finland

Depressive episode, unspecified

12.0

307.7

1148

898

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.5

307.7

1843

5116

N06AX16

ATC

venlafaxine; oral

4.8

307.7

1323

2600

I25.2

ICD-10 Finland

Old myocardial infarction

1450.3

307.7

776

C01DA14

ATC

isosorbide mononitrate; oral

28.5

307.7

1649

579

C07AB02

ATC

metoprolol; systemic

4.2

307.7

1774

4106

207

Kela drug reimbursment

Chronic arrhythmias

300.9

307.7

1592

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

307.7

468

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

924.5

307.7

421

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

7.5

307.7

1776

2348

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

47.9

307.7

539

100

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

1046

J45.9

ICD-10 Finland

Asthma, unspecified

3.5

307.7

2139

6043

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

141.1

307.7

539

M10.9

ICD-10 Finland

Gout, unspecified

5.9

307.7

870

1348

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

1381

160

Kela drug reimbursment

exenatide

+∞

307.7

334

A10AC01

ATC

insulin (human); parenteral

70.3

307.7

750

E66.01

ICD-10 Finland

Obesity due to excess calories

35.0

307.7

1702

491

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.9

307.7

595

666

E66.9

ICD-10 Finland

Obesity, unspecified

50.1

307.7

541

T90

ICPC

Diabetes non-insulin dependent

38.1

307.7

3164

1014

SPAT1263

SPAT

Sampling

2.5

307.7

3932

17245

WX882

NOMESCO Finland

High dependency care

14.0

307.7

827

538

A10AB05

ATC

insulin aspart; parenteral

153.3

307.7

819

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.0

307.7

902

1369

R06.5

ICD-10 Finland

Mouth breathing

3.7

307.7

1354

3431

XCK10

NOMESCO Finland

Photography of fundus of eye

4.5

307.7

932

1898

I20.99

ICD-10 Finland

Angina pectoris, unspecified

94.4

307.7

551

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.3

307.7

762

1086

WX725

NOMESCO Finland

Noninvasive ventilation

+∞

307.7

554

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.0

307.7

3118

8637

XG410

NOMESCO Finland

Flow-volume spirometry

8.9

307.7

704

709

Z3226

NOMESCO Finland

Physiotherapist

3.9

307.7

2540

6740

A10BJ02

ATC

liraglutide; parenteral

167.6

307.7

474

SPAT1254

SPAT

Administration of medicine

3.5

307.7

1383

3651

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3494.2

307.7

407

N06AX11

ATC

mirtazapine; oral

2.6

307.7

2996

12001

N17.9

ICD-10 Finland

Acute renal failure, unspecified

8.6

307.7

503

517

A10BH01

ATC

sitagliptin; oral

1470.3

307.7

1208

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3219.3

307.7

728

T82

ICPC

Obesity

16.7

307.7

674

362

XF404

NOMESCO Finland

Ambulatory ECG

13.2

307.7

990

698

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

61.9

307.7

496

R02

ICPC

Shortness of breath/dyspnoea

4.7

307.7

1455

2950

I42.0

ICD-10 Finland

Dilated cardiomyopathy

37.0

307.7

319

H02AB06

ATC

prednisolone; systemic

2.5

307.7

4968

24001

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

16.5

307.7

814

451

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

2752

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1040.2

307.7

582

R04

ICPC

Breathing problem other

7.7

307.7

706

824

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

95.3

307.7

840

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.9

307.7

799

918

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

5.2

307.7

2243

4443

I48

ICD-10 Finland

Atrial fibrillation and flutter

146.6

307.7

2407

182

C10AA01

ATC

simvastatin; oral

3.4

307.7

4338

15340

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.0

307.7

2560

2795

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

19.2

307.7

518

239

WX722

NOMESCO Finland

PEEP

+∞

307.7

9947

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

307.7

528

AN1

Coronary angiography

213.3

307.7

1124

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

307.7

440

A10BA02

ATC

metformin; oral

109.4

307.7

3746

460

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

723.1

307.7

1588

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.7

307.7

2271

8228

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

7.0

307.7

2299

3455

WX730

NOMESCO Finland

Conventional respirator

42.5

307.7

540

113

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

8.9

307.7

824

845

T89

ICPC

Diabetes insulin dependent

95.2

307.7

275

A10BB01

ATC

glibenclamide; oral

189.2

307.7

326

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

14.1

307.7

3025

2516

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

6368.6

307.7

712

I20.09

ICD-10 Finland

Unstable angina

220.4

307.7

521

B01AA03

ATC

warfarin; systemic

14.0

307.7

2071

1540

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

94.8

307.7

295

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

63.5

307.7

419

B01AF02

ATC

apixaban; oral

17.0

307.7

1250

703

XF400

NOMESCO Finland

ECG with 12 standard connections

8.2

307.7

2717

3665

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

33.7

307.7

563

149

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.8

307.7

1260

3087

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

77.5

307.7

295

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

27.6

307.7

452

144

TPH07

NOMESCO Finland

Cathetrisation of artery

8.1

307.7

1913

2380

E66

ICD-10 Finland

Obesity

9.8

307.7

741

685

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

307.7

507

N03AX16

ATC

[U] pregabalin

3.0

307.7

2557

8629

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.8

307.7

781

1213

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

8.9

307.7

973

1013

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.4

307.7

1001

2072

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

64.7

307.7

1710

268

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

33.6

307.7

402

105

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.3

307.7

5884

17868

C01AA05

ATC

digoxin; systemic

31.0

307.7

797

235

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

20.9

307.7

738

320

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

12.7

307.7

947

690

C02AC05

ATC

moxonidine; oral

7.3

307.7

547

660

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

6.7

307.7

798

1071

A10AB04

ATC

insulin lispro; parenteral

200.0

307.7

232

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.3

307.7

1578

4470

N02AX02

ATC

tramadol; systemic, rectal

2.6

307.7

4633

21085

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

13.7

307.7

457

294

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

30.1

307.7

750

226

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.5

307.7

2777

4107

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

827

T36

ICD-10 Finland

Poisoning by systemic antibiotics

16.8

307.7

335

173

R5140

NOMESCO Finland

Monitoring the use of the aid

17.3

307.7

3996

3130

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

170.4

307.7

1272

F34.1

ICD-10 Finland

Dysthymia

14.7

307.7

334

197

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

101.4

307.7

568

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

6.2

307.7

1717

2722

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

88.3

307.7

3240

456

TKC20

NOMESCO Finland

Catheterisation of bladder

7.5

307.7

1306

1660

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.6

307.7

2778

3605

B01AC04

ATC

clopidogrel; oral

12.2

307.7

1646

1336

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

7.4

307.7

968

1199

C08CA01

ATC

amlodipine; oral

3.2

307.7

4228

15659

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

48.8

307.7

538

C09AA05

ATC

ramipril; oral

4.8

307.7

2718

6050

I25.1

ICD-10 Finland

Atherosclerotic heart disease

152.3

307.7

2436

178

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.7

307.7

1337

2206

ZX120

NOMESCO Finland

Intravenous

4.4

307.7

1476

3175

TPH04

NOMESCO Finland

Cathetrisation of vein

4.7

307.7

2802

6442

Z2446

NOMESCO Finland

Social worker

7.1

307.7

1040

1346

J01MA12

ATC

levofloxacin; systemic

3.0

307.7

2206

7215

Z2221

NOMESCO Finland

Medical doctor

3.4

307.7

3454

11469

N06AB10

ATC

escitalopram; oral

3.0

306.7

1637

5150

C03AA03

ATC

hydrochlorothiazide; oral

4.1

305.4

941

2065

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

25.7

305.3

241

SPAT1054

SPAT

Examination of peripheral nervous system

48.7

304.7

204

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.4

303.1

1298

3576

XG405

NOMESCO Finland

Education on PEF monitoring

11.8

303.0

343

253

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.2

302.8

1463

4341

I20.00

ICD-10 Finland

Unstable angina

2627.3

302.4

311

A10BJ05

ATC

dulaglutide; parenteral

+∞

299.9

306

K77

ICPC

Heart failure

28.3

296.8

227

I47.1

ICD-10 Finland

Supraventricular tachycardia

20.9

296.4

252

104

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.4

295.3

836

1717

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

7.5

295.1

467

548

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.7

294.7

2026

7291

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.7

294.6

760

1447

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.7

288.0

750

1439

N05AX12

ATC

aripiprazole; systemic

24.8

287.9

230

B01AC06

ATC

acetylsalicylic acid; oral

33.3

286.2

209

N06AB03

ATC

fluoxetine; oral

3.7

285.5

1041

2575

SPAT1104

SPAT

Monitoring of emergency patient

4.6

284.8

752

1459

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.0

284.5

423

460

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

39.5

283.1

198

OAB50, ,

SPAT

7.1

282.7

466

573

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

5.0

282.4

680

1220

F29

ICD-10 Finland

Unspecified nonorganic psychosis

69.4

281.7

178

SPAT1216

SPAT

Assessment of functional ability

3.0

281.1

1525

4827

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.1

278.1

462

573

N05CF01

ATC

zopiclone; oral

2.3

277.6

2923

12781

B01AF01

ATC

rivaroxaban; oral

3.3

277.3

1213

3378

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

63.2

276.4

177

N05AH03

ATC

olanzapine; systemic

8.7

276.2

384

383

N05AA02

ATC

levomepromazine; systemic

11.1

275.4

323

252

B01AC24

ATC

ticagrelor; oral

822.6

272.8

285

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.3

272.7

1204

3371

C08DB01

ATC

diltiazem; oral

6.8

272.5

469

605

A10BG03

ATC

pioglitazone; oral

417.6

272.5

290

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

272.0

2748

11788

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

313.5

270.3

291

J01FF01

ATC

clindamycin; systemic

2.3

268.2

2714

11640

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

31.9

266.8

197

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.4

264.0

2399

9805

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

32.8

260.6

191

A02BC05

ATC

esomeprazole; systemic

2.1

260.0

3850

19217

WX002

NOMESCO Finland

Sedation and analgesia

2.5

259.1

2100

8137

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

4.3

258.9

756

1587

N03AX09

ATC

lamotrigine; oral

7.9

258.7

390

431

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

10.2

257.9

320

272

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

15.1

256.9

253

145

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

4.0

256.8

829

1877

J01DB01

ATC

cefalexin; oral

2.4

255.4

8032

53177

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

769.1

255.1

267

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

254.8

1223

3595

C08CA13

ATC

lercanidipine; oral

2.9

251.8

1384

4396

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

+∞

251.6

257

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.2

251.0

741

1568

P76

ICPC

Depressive disorder

6.4

250.3

456

625

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

29.0

248.9

189

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

1115.2

248.2

258

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

247.7

253

N02BE01

ATC

paracetamol; systemic, rectal

2.6

247.7

8553

58533

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

247.0

5093

28558

S97

ICPC

Chronic ulcer skin

4.9

246.3

597

1075

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

41.3

244.1

169

UJF32

NOMESCO Finland

Coloscopy

2.3

242.8

2483

10633

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

730.6

242.4

254

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

60.6

242.0

156

K90

ICPC

Stroke/cerebrovascular accident

20.0

241.5

209

RK110, ,

NOMESCO Finland

17.3

240.0

221

110

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

14.7

240.0

239

140

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

239.8

245

B01AB05

ATC

enoxaparin; parenteral

2.2

239.5

2950

13620

XF640, ,

NOMESCO Finland

10.5

239.2

290

238

A28

ICPC

Limited function/disability NOS

2.8

238.9

1429

4744

ZXE20

NOMESCO Finland

More than three and less than five hours

2.9

238.4

1361

4406

P03

ICPC

Feeling depressed

4.5

236.3

640

1264

N19

ICD-10 Finland

Unspecified kidney failure

6.9

236.2

398

501

SPAT1229

SPAT

Assessment of need for aid

3.9

235.6

773

1768

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.6

234.6

415

551

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

233.9

239

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

358.1

233.5

250

SPAT1240

SPAT

Therapeutic discussion

4.0

233.5

735

1631

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

233.2

958

2553

XA420

NOMESCO Finland

Extensive sleep examination

12.3

233.2

256

179

A08

ICPC

Swelling

4.8

231.6

572

1046

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1988.6

231.6

239

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

231.4

855

2125

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

9.5

231.1

300

272

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

5.3

230.5

511

849

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.3

229.0

367

436

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

+∞

229.0

234

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.9

228.8

549

979

A10AE06

ATC

insulin degludec; parenteral

1962.2

228.6

236

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.1

228.4

284

242

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

12.8

228.1

245

165

WX890

NOMESCO Finland

Intesive care monitoring

40.0

227.9

159

N06AB06

ATC

sertraline; oral

3.7

227.9

821

2005

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1953.4

227.7

235

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

84.8

225.6

139

N05CD07

ATC

temazepam; oral

3.2

225.2

1020

2887

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

225.1

4274

23034

SPAT1097

SPAT

Recording of ECG

2.9

224.3

1225

3864

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.7

223.8

569

1066

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

223.3

1338

4437

A04

ICPC

Weakness/tiredness general

2.9

222.5

1193

3724

C08CA02

ATC

felodipine; oral

3.4

220.4

883

2313

AN3

Balloon angioplasty and metallic stent

+∞

220.2

225

SPAT1310

SPAT

Counselling related to known health issue

2.2

220.0

2658

12113

XF600

NOMESCO Finland

Bloodpressure measurement

4.2

218.9

654

1394

I20.01

ICD-10 Finland

Unstable angina

1865.6

217.9

225

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1856.8

216.9

224

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.7

214.4

774

1891

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

6.2

214.0

403

571

R5110, ,

SPAT

3.7

213.3

751

1803

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

5.6

213.3

443

692

GD1AD

NOMESCO Finland

Thorax CT examination

4.0

212.1

658

1442

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

211.6

3920

20826

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

17.0

211.4

196

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

29.1

211.2

160

C07AA07

ATC

sotalol; systemic

9.3

210.5

277

256

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

942.0

210.0

219

F61.0

ICD-10 Finland

Mixed personality disorders

55.7

209.6

137

N05BA01

ATC

diazepam; systemic, rectal

3.0

207.8

1063

3226

C09CA01

ATC

losartan; oral

2.2

206.6

2388

10656

5CM18, ,

NOMESCO Finland

243.4

206.3

225

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

205.4

210

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.0

205.0

652

1455

R03BA05

ATC

fluticasone; inhalant

2.4

204.4

1799

7161

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.7

203.1

516

965

C07AG02

ATC

carvedilol; oral

4.5

202.9

544

1064

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

202.8

3074

15173

AN4

Balloon angioplasty and drug eluding stent

+∞

202.5

207

AA1

Conventional CABG

+∞

202.5

207

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.1

202.2

622

1354

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1725.4

202.2

209

A02BC01

ATC

omeprazole; systemic

2.2

202.1

2351

10505

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

25.7

201.7

159

G47.9

ICD-10 Finland

Sleep disorder, unspecified

6.0

201.2

388

563

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

902.4

201.2

210

R4120

NOMESCO Finland

Occupational therapy

3.6

200.5

726

1775

N06AX26

ATC

vortioxetine; oral

4.6

199.6

524

1007

A10AA02, ,

ATC

601.0

199.4

210

N07BB01

ATC

disulfiram; oral

6.3

197.3

362

499

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

196.6

3899

21060

A11CC03

ATC

alfacalcidol; systemic

7.8

196.6

298

331

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

17.9

194.7

176

L17

ICPC

Foot/toe symptom/complaint

2.1

194.6

2510

11647

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.3

194.4

828

2250

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

29.2

194.2

147

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.2

194.1

440

745

1CX08, ,

NOMESCO Finland

580.5

192.5

203

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

192.5

6622

42603

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1638.1

192.4

199

A06AD11

ATC

lactulose; oral

2.6

191.5

1276

4448

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

190.8

2572

12119

A10BX07

ATC

[U] liraglutide

+∞

190.7

195

H02AB04

ATC

methylprednisolone; systemic

2.5

190.5

1473

5515

I44.2

ICD-10 Finland

Atrioventricular block, complete

10.3

190.2

233

194

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.4

189.9

1570

6061

N05BA12

ATC

alprazolam; oral

3.1

189.9

874

2489

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

18.1

189.7

171

XG474

NOMESCO Finland

Exhalation nntrogen oxide

5.9

188.6

372

552

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.7

187.5

654

1557

B01AC07

ATC

dipyridamole; systemic

7.2

187.4

304

366

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

6.4

186.6

336

454

RK520, ,

NOMESCO Finland

20.1

185.8

160

RK510, ,

NOMESCO Finland

76.0

185.7

116

N06AA09

ATC

amitriptyline; systemic

3.2

185.6

832

2331

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.2

185.4

813

2247

R4110, ,

SPAT

2.9

185.4

982

3031

TK810

NOMESCO Finland

Hemofiltration

35.5

185.3

133

F41.1

ICD-10 Finland

Generalized anxiety disorder

7.7

184.4

281

314

C10AA07

ATC

rosuvastatin; oral

2.0

184.3

2777

13595

I47.2

ICD-10 Finland

Ventricular tachycardia

217.2

184.0

202

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

183.8

188

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

554.2

183.8

194

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

181.7

946

2891

RK250, ,

NOMESCO Finland

22.7

181.3

149

M79.6

ICD-10 Finland

Pain in limb

1.9

181.0

3707

20095

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.2

180.9

521

1077

F32

ICD-10 Finland

Depressive episode

5.1

180.8

410

694

R42

ICD-10 Finland

Dizziness and giddiness

2.2

180.6

1861

7881

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.2

180.6

520

1075

R95

ICPC

Chron obstructive pulmonary disease

6.3

180.4

331

456

3AC01, ,

NOMESCO Finland

14.4

179.9

181

108

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

6.0

179.4

345

499

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

179.2

2694

13156

4019X

ICD-9 Finland

Essential hypertension, Unspecified

9.6

179.2

230

205

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.2

178.9

779

2143

RD210, ,

NOMESCO Finland

8.5

178.7

251

253

Single vessel balloon catheter extension

+∞

177.9

182

C10AA04

ATC

fluvastatin; oral

3.4

177.7

718

1884

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

176.8

1115

3773

J01DA01

ATC

[U] cefalexin

1.8

175.9

5642

35028

N18.0

ICD-10 Finland

End-stage renal disease

17.1

175.4

162

C09BA02

ATC

enalapril and diuretics; systemic

3.2

175.2

760

2085

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

175.0

2030

8999

AP1

Catheterization of the left side of the heart

524.9

174.0

184

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

30.6

172.7

129

DHB50

NOMESCO Finland

Turbinoplasty

4.9

172.4

411

727

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

172.3

1934

8459

162

Kela drug reimbursment

liraglutide

+∞

172.0

176

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.9

171.6

554

1247

ZXA00

NOMESCO Finland

Right side

2.0

170.8

2594

12678

C08DA01

ATC

verapamil; systemic

6.0

170.4

325

466

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

170.1

174

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

+∞

170.1

174

E87.5

ICD-10 Finland

Hyperkalaemia

12.4

169.4

185

128

SPAT1211

SPAT

Application of soft bandage

3.0

169.2

866

2618

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.0

168.7

533

1181

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.5

168.2

1267

4670

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

1555.4

167.9

174

F10.09

ICD-10 Finland

Alcohol intoxication UNS

58.0

167.8

109

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

167.7

1058

3577

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

9.9

167.5

211

183

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.6

167.3

435

828

J46

ICD-10 Finland

Status asthmaticus

6.4

167.2

302

409

J01AA02

ATC

doxycycline; systemic

1.9

166.7

7431

50680

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.1

166.4

504

1082

RK290, ,

NOMESCO Finland

37.2

166.4

118

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

166.3

1494

5956

A02BA02

ATC

ranitidine; systemic

2.2

166.1

1640

6803

N05AB03

ATC

perphenazine; systemic, rectal

10.0

166.0

208

179

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

86.8

165.8

102

J81

ICD-10 Finland

Pulmonary oedema

43.7

165.2

113

SPAT1051

SPAT

Guidance regarding sleep disorders

8.0

164.6

243

261

J01CA04

ATC

amoxicillin; systemic

2.0

164.5

7627

52557

C09DA01

ATC

losartan and diuretics; oral

2.6

164.0

1058

3615

R03DA04

ATC

theophylline; systemic, rectal

3.9

163.5

530

1196

M54.5

ICD-10 Finland

Low back pain

1.9

163.0

3078

16136

R03BA02

ATC

budesonide; inhalant

2.2

162.5

1634

6825

F10.20

ICD-10 Finland

Alcohol dependence currently independent

26.9

162.3

126

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

18.6

162.0

144

ZXA05

NOMESCO Finland

Left side

2.0

161.5

2401

11615

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.2

161.1

472

988

M10.0

ICD-10 Finland

Idiopathic gout

5.2

160.9

363

611

A10BX01

ATC

guar gum; oral

7.1

160.5

263

320

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

160.2

1696

7229

J96.9

ICD-10 Finland

Respiratory failure, unspecified

30.1

159.9

120

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

159.9

3571

19702

E66.0

ICD-10 Finland

Obesity due to excess calories

249.9

159.7

174

R4190

NOMESCO Finland

Nutritional therapy

4.1

159.7

485

1043

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.1

159.5

299

421

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

159.5

994

3336

CL2S4, ,

SPAT

291.0

158.3

171

N05AF03

ATC

chlorprothixene; systemic

19.8

158.2

137

R99

ICPC

Respiratory disease other

7.0

158.0

260

318

Coronary artery bypass surgery

+∞

157.3

161

A10AA01, ,

ATC

705.5

157.2

165

R01AD08

ATC

fluticasone; nasal

1.9

157.1

2724

13860

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

11.4

156.4

179

134

M10

ICD-10 Finland

Gout

4.0

156.3

484

1056

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.7

156.1

238

266

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.2

155.9

701

1962

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

155.4

159

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.6

154.9

550

1323

Z2445

NOMESCO Finland

Psychologist

5.6

154.3

320

498

A10BH02

ATC

vildagliptin; oral

692.4

154.3

162

B01AE07

ATC

dabigatran etexilate; oral

6.4

154.2

277

373

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

153.9

2269

10918

N05BE01

ATC

buspirone; oral

7.5

153.9

239

273

J45

ICD-10 Finland

Asthma

2.6

153.9

984

3343

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

11.7

153.7

173

126

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.9

153.6

805

2462

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

38.3

153.3

108

K84

ICPC

Heart disease other

12.0

152.4

169

120

Z49.1

ICD-10 Finland

Extracorporeal dialysis

12.5

152.0

165

113

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

48.2

152.0

102

WX704

NOMESCO Finland

Intubation

3.4

151.2

602

1562

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

20.2

151.1

130

N02AA05

ATC

oxycodone; systemic

2.2

151.0

1586

6725

J45.1

ICD-10 Finland

Nonallergic asthma

3.1

150.7

680

1907

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

8.9

150.0

204

197

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

6.7

149.9

257

329

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.8

149.7

225

247

RS221, ,

NOMESCO Finland

8.7

149.7

206

202

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.9

149.7

291

425

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

58.9

149.7

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

14.9

149.3

147

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

340.5

149.1

160

A99

ICPC

Disease/condition unspecnature/site

2.7

148.9

896

2949

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.7

148.4

520

1239

N03AG01

ATC

valproic acid; systemic, rectal

4.1

148.3

437

918

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.7

148.2

522

1248

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

148.1

1627

7017

A10BX04

ATC

[U] exenatide

+∞

147.5

151

UKC02

NOMESCO Finland

Cystoscopy

2.2

147.5

1492

6227

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

661.9

147.5

155

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

1340.2

147.4

153

R04.0

ICD-10 Finland

Epistaxis

3.2

147.1

633

1724

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.2

146.9

657

1832

AN2

Balloon angioplasty, including several vessels

+∞

146.6

150

J01FA06

ATC

roxithromycin; oral

1.8

146.3

3531

19808

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

17.9

145.9

132

N06AA12

ATC

doxepin; systemic

4.2

145.8

426

889

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.8

145.6

489

1131

F10.25

ICD-10 Finland

Alcohol dependence continuous use

33.4

145.4

106

C10AA03

ATC

pravastatin; oral

3.5

145.4

557

1409

H25.8

ICD-10 Finland

Other senile cataract

2.5

145.3

1048

3771

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

13.2

144.8

152

K07

ICPC

Swollen ankles/oedema

4.3

144.7

406

821

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.2

144.6

636

1755

K99

ICPC

Cardiovascular disease other

7.6

144.4

223

253

R00.1

ICD-10 Finland

Bradycardia, unspecified

6.6

144.2

250

324

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

144.0

2968

15869

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.9

143.9

153

101

J01MA02

ATC

ciprofloxacin; systemic

1.8

143.8

3518

19791

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.4

143.5

225

260

IGY02

NOMESCO Finland

Psychiatric monitoring contact

9.9

142.8

179

154

N03AX12

ATC

[U] gabapentin; oral

2.3

142.5

1286

5115

ZXE00

NOMESCO Finland

One hour or less

1.8

142.4

3391

18913

C09CA06

ATC

candesartan; oral

1.9

142.4

2183

10610

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

142.0

1130

4253

F41.00

ICD-10 Finland

Moderate panic disorder

40.1

142.0

A41.9

ICD-10 Finland

Sepsis, unspecified

4.7

141.8

357

661

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.2

141.5

404

828

ZXE90

NOMESCO Finland

More than 22 hours

19.4

140.8

123

A02BC03

ATC

lansoprazole; oral

1.9

140.5

2333

11636

L03

ICPC

Low back symptom/complaint

1.9

140.5

2275

11254

R06.2

ICD-10 Finland

Wheezing

3.8

139.6

471

1092

IGY99

NOMESCO Finland

Other psychiatric treatment contact

10.1

139.2

173

147

K76

ICPC

Ischaemic heart dis without angina

25.3

139.0

110

WX320

NOMESCO Finland

Spinalanesthesy

1.9

138.8

2341

11728

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

138.8

1190

4627

J01MA14

ATC

moxifloxacin; systemic

2.7

138.8

869

2916

R2110

NOMESCO Finland

Giving the first information

3.1

138.4

638

1810

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

9.2

138.4

183

170

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

11.4

138.2

158

118

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

13.4

137.9

144

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

29.5

137.8

104

A10AD05

ATC

insulin aspart; parenteral

414.4

137.0

146

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

5.7

136.8

275

415

SPAT1325

SPAT

Vaccination

1.8

136.5

2843

15202

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

136.3

3052

16672

P01

ICPC

Feeling anxious/nervous/tense

3.1

136.3

614

1718

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

15.8

135.9

130

A10BJ01

ATC

exenatide; parenteral

+∞

135.8

139

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

135.8

920

3209

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

29.9

135.7

102

R51.80

ICD-10 Finland

Headache

2.3

135.7

1149

4441

J20

ICD-10 Finland

Acute bronchitis

2.5

135.1

946

3352

P01AB01

ATC

metronidazole; oral, rectal

1.7

134.8

3433

19448

WNF00

NOMESCO Finland

Infection source and contact determination

25.8

134.7

106

SPAT1234

SPAT

Support of social functional capacity

4.1

134.3

403

858

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.5

134.0

961

3443

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

134.0

922

3239

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

14.5

133.9

134

A10BD03

ATC

metformin and rosiglitazone; systemic

+∞

133.8

137

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

133.8

137

N18.8

ICD-10 Finland

Other chronic renal failure

6.8

132.9

225

284

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.0

132.8

311

541

R07.3

ICD-10 Finland

Other chest pain

2.7

132.7

776

2512

J37.0

ICD-10 Finland

Chronic laryngitis

4.3

132.1

372

754

XG460

NOMESCO Finland

Short time oxymetry

7.3

131.7

209

245

C09CA03

ATC

valsartan; oral

2.6

131.6

839

2838

NHQ40

NOMESCO Finland

Amputation of toe

10.5

131.3

159

130

ZY010

NOMESCO Finland

Hospital outpatient

4.3

130.8

361

720

A08AB01

ATC

orlistat; oral

46.7

130.3

RK120, ,

NOMESCO Finland

20.8

129.5

110

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.3

128.3

183

188

RS220, ,

NOMESCO Finland

8.4

127.4

181

185

R03DC03

ATC

montelukast; oral

2.1

127.3

1437

6234

R03BB01

ATC

ipratropium bromide; inhalant

4.1

126.7

377

797

M79.7

ICD-10 Finland

Fibromyalgia

5.1

126.5

286

482

K28

ICPC

Limited function/disability (K)

7.4

125.9

197

227

R05FB02

ATC

cough suppressants and expectorants; systemic

1.7

125.7

3308

18826

3051, ,

Kela drug reimbursment

23.4

125.6

102

N05BA06

ATC

lorazepam; systemic, sublingual

3.8

125.3

421

973

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

21.0

125.2

106

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

125.2

1036

3957

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

562.1

125.1

132

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

124.8

596

1724

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

2.1

123.3

1326

5641

H3601, E113,

ICD-10 Finland

+∞

123.0

126

280

Kela drug reimbursment

Clopidogrel

+∞

123.0

126

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

11.8

122.9

138

100

F32.1

ICD-10 Finland

Moderate depressive episode

4.5

122.3

319

608

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.8

121.9

671

2101

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

121.7

2539

13501

SPAT1281

SPAT

Other administrative function

2.8

121.4

665

2077

A10BG02

ATC

rosiglitazone; oral

1073.9

121.0

126

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

19.2

120.8

106

R96

ICPC

Asthma

2.6

120.8

804

2775

Z49.0

ICD-10 Finland

Preparatory care for dialysis

11.2

120.7

140

107

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.3

120.5

1105

4407

N03AE01

ATC

clonazepam; systemic

3.4

120.4

462

1168

R32

ICD-10 Finland

Unspecified urinary incontinence

4.7

120.3

303

561

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

120.2

3109

17562

F99

ICD-10 Finland

Mental disorder, not otherwise specified

10.4

120.1

146

120

N06AB05

ATC

paroxetine; oral

3.5

120.0

440

1079

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

120.0

4946

31526

B03XA02

ATC

darbepoetin alfa; parenteral

5.8

119.5

235

347

F41.09

ICD-10 Finland

UNS Panic Syndrome

9.5

119.5

154

138

I20.91

ICD-10 Finland

Angina pectoris, unspecified

536.1

119.2

126

K29

ICPC

Cardiovascular sympt/complt other

4.0

119.0

366

793

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

55.2

119.0

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.5

118.7

816

2860

R50.9

ICD-10 Finland

Fever, unspecified

2.1

118.7

1278

5435

N02BF02

ATC

pregabalin; oral

3.2

118.3

509

1383

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

118.3

635

1961

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.7

118.3

407

956

M48.0

ICD-10 Finland

Spinal stenosis

2.3

118.1

1044

4098

NF1AA

NOMESCO Finland

Hip X-ray examination

2.5

118.0

842

3003

A12AA04

ATC

calcium carbonate; oral

7.9

118.0

175

189

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.2

117.8

340

702

M01AB01

ATC

indometacin; systemic, rectal

2.6

117.7

741

2487

R55

ICD-10 Finland

Syncope and collapse

2.5

117.6

813

2856

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.8

117.4

287

518

N05AX08

ATC

risperidone; systemic

3.3

117.0

483

1279

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.7

116.8

234

352

F60.9

ICD-10 Finland

Personality disorder, unspecified

30.8

116.7

B01AF03

ATC

edoxaban; oral

20.2

116.5

100

N04BC05

ATC

pramipexole; oral

2.7

116.5

720

2394

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.0

116.4

549

1576

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

116.3

562

1636

SPAT1100

SPAT

Long-term monitoring of blood pressure

3.1

115.8

537

1526

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.8

115.5

2484

13294

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.6

115.5

413

996

RD112, ,

NOMESCO Finland

62.8

115.2

N05AN01

ATC

lithium; oral

10.6

115.1

138

111

L15

ICPC

Knee symptom/complaint

1.8

115.0

2109

10762

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.9

114.8

269

468

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

114.7

663

2129

WX723

NOMESCO Finland

CPAP therapy

3.4

114.2

450

1157

NG2AA

NOMESCO Finland

Patella X-ray examination

3.9

114.2

369

829

RK323, ,

NOMESCO Finland

25.5

114.0

ZY000

NOMESCO Finland

Hospital inpatient

15.2

114.0

111

WX900

NOMESCO Finland

Resuscitation

33.6

114.0

R4140

NOMESCO Finland

Psychotherapy

46.7

113.9

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

345.0

113.8

122

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

113.4

734

2496

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

12.5

113.4

123

C08CA05

ATC

nifedipine; systemic

3.2

113.4

480

1291

WW200

NOMESCO Finland

Immunization

4.2

113.3

330

686

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

113.3

116

N06AX03

ATC

mianserin; oral

4.1

113.2

332

694

R60.9

ICD-10 Finland

Oedema, unspecified

3.3

113.0

469

1246

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

12.9

113.0

120

V03AE01

ATC

polystyrene sulfonate; oral

10.2

112.5

138

115

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

505.9

112.4

119

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

10.7

112.3

134

107

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

261.9

112.3

122

N06AG02

ATC

moclobemide; oral

4.0

112.3

344

743

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

112.3

115

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

112.3

115

Catheterization and pressure measurement of the left side of the heart

48.9

112.0

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

48.9

112.0

P15

ICPC

Chronic alcohol abuse

6.6

111.0

192

248

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.7

110.6

189

241

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

7.6

110.3

169

190

C02EA02, ,

ATC

4.1

110.0

325

683

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.9

110.0

346

762

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

119.4

110.0

126

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

109.5

706

2395

XKD00

NOMESCO Finland

Uroflowmetry

1.9

109.5

1550

7263

C09AA04

ATC

perindopril; oral

3.3

109.5

457

1218

I20

ICD-10 Finland

Angina pectoris

13.8

109.3

112

M01AE02

ATC

naproxen; oral, rectal

1.6

109.2

5086

33099

Z72.0

ICD-10 Finland

Tobacco use

5.9

109.2

213

312

G04CA02

ATC

tamsulosin; oral

1.8

108.9

2176

11370

EB1MA

NOMESCO Finland

Cephalometry with X-ray

4.6

108.9

275

510

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.7

108.9

377

889

R03AC13

ATC

formoterol; inhalant

3.2

108.8

464

1253

K05.31

ICD-10 Finland

Periodontitis pronounced

2.3

108.8

972

3827

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.4

108.6

292

570

WW500

NOMESCO Finland

Blood transfusion

3.3

108.4

441

1157

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

3.8

108.2

355

806

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

108.1

3285

19243

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

106.7

1682

8162

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.7

106.7

266

488

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

6.4

106.5

189

251

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

+∞

106.4

109

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.9

106.3

533

1583

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

9.4

106.2

138

125

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

12.0

106.2

118

R05

ICD-10 Finland

Cough

1.8

106.2

1857

9311

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

106.1

1259

5538

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

105.7

1949

9931

A10AB06

ATC

insulin glulisine; parenteral

+∞

105.4

108

R03BA08

ATC

ciclesonide; inhalant

2.4

105.4

777

2809

K91

ICPC

Cerebrovascular disease

16.0

105.3

100

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

5.2

105.3

233

385

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.0

105.2

241

411

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.9

105.0

523

1548

F31.8

ICD-10 Finland

Other bipolar affective disorders

13.4

104.9

109

C08CA07

ATC

nisoldipine; oral

22.8

104.9

SPAT1252

SPAT

Overall medication plan or its review

3.1

104.8

480

1353

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

16.8

104.5

NOMESCO Finland

Other rehabilitation services

+∞

104.4

107

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

104.2

1927

9823

K03.66

ICD-10 Finland

Tooth plaque

2.5

103.8

747

2670

R11

ICD-10 Finland

Nausea and vomiting

2.7

103.8

612

1984

R05

ICPC

Cough

1.8

103.6

1945

9958

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

103.5

106

PD5AD

NOMESCO Finland

CT of aorta

6.9

103.3

172

213

K92.1

ICD-10 Finland

Melaena

3.3

103.0

412

1069

R03AC12

ATC

salmeterol; inhalant

3.4

102.8

407

1049

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

102.7

1289

5782

E10

ICD-10 Finland

Type 1 diabetes mellitus

239.5

102.7

112

H3600, E113,

ICD-10 Finland

+∞

102.5

105

I45.9

ICD-10 Finland

Conduction disorder, unspecified

17.6

102.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.6

102.1

208

318

C09DA06

ATC

candesartan and diuretics; oral

2.5

101.9

700

2447

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

101.5

104

E0000UV, ,

ATC

1.6

100.9

3527

21303

C07AB03

ATC

atenolol; systemic

3.4

100.7

395

1012

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.9

100.6

236

411

R03AK11

ATC

formoterol and fluticasone; inhalant

4.3

100.5

278

555

F32.8

ICD-10 Finland

Other depressive episodes

14.3

100.5

101

T92

ICPC

Gout

5.7

100.1

199

297

SPAT1301

SPAT

No procedures

1.7

100.0

2265

12226

ZXD00

NOMESCO Finland

Emergency procedure

4.7

99.9

247

450

J01MA01

ATC

ofloxacin; systemic

2.3

99.7

823

3128

S18

ICPC

Laceration/cut

1.6

99.6

3883

24053

PD5BD

NOMESCO Finland

Extensive CT of aorta

7.4

99.6

156

180

K29.3

ICD-10 Finland

Chronic superficial gastritis

4.2

99.6

281

570

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.9

99.5

506

1514

I20.0

ICD-10 Finland

Unstable angina

47.3

99.3

N06AX05

ATC

trazodone; oral

6.0

99.1

187

265

C07AB08

ATC

celiprolol; oral

5.5

98.8

207

325

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

98.6

101

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

98.6

101

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

98.6

101

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

875.6

98.6

103

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

98.2

2094

11105

H03AA01

ATC

levothyroxine sodium; systemic

1.8

98.0

1791

9078

R31

ICD-10 Finland

Unspecified haematuria

2.3

98.0

871

3416

J01CF05

ATC

flucloxacillin; systemic

2.8

98.0

548

1727

PE1AT

NOMESCO Finland

Femoral artery PTA

12.3

97.9

107

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

16.8

97.9

H04AA01

ATC

glucagon; nasal, parenteral

119.2

97.8

112

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.5

97.7

253

479

RK123, ,

NOMESCO Finland

867.0

97.6

102

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

97.4

738

2699

K02.1

ICD-10 Finland

Caries of dentine

1.6

97.3

5023

33123

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.1

97.2

286

599

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

97.2

1905

9856

AS4

Physiological pacemaker insertion DDD (R)

19.8

97.0

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

19.8

97.0

SPAT1255

SPAT

Intravenous administration of medicine

2.8

96.9

549

1742

-48

ICPC

Clarification/discussion RFE/demand

4.8

96.8

237

428

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

96.6

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

96.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.8

96.4

512

1569

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

96.2

580

1900

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

7.4

96.0

151

175

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

13.6

95.8

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.5

95.7

675

2388

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

+∞

95.6

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

6.2

95.2

176

244

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

95.2

5976

41087

R03AK08

ATC

formoterol and beclometasone; inhalant

3.2

95.2

403

1083

WX290

NOMESCO Finland

Other blockage of nerve

1.6

95.1

3780

23447

F10.24

ICD-10 Finland

Alcohol depence active use

22.8

95.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

95.1

941

3854

R29

ICPC

Respiratory symptom/complaint other

2.6

94.5

586

1947

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

19.0

94.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.5

93.8

346

851

A01

ICPC

Pain general/multiple sites

2.5

93.8

669

2379

A10BD20

ATC

metformin and empagliflozin; oral

832.6

93.7

C09DX04

ATC

valsartan and sacubitril; oral

832.6

93.7

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

+∞

93.7

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.2

93.5

173

240

M79.1

ICD-10 Finland

Myalgia

2.0

93.5

1146

5087

A11

ICPC

Chest pain NOS

2.7

93.3

548

1771

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

4.8

93.2

223

395

UJD02

NOMESCO Finland

Gastroscopy

3.4

93.1

368

947

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

8.9

92.8

125

119

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

92.5

3900

24477

E86

ICD-10 Finland

Volume depletion

5.5

92.4

190

293

R01AD58

ATC

fluticasone, combinations; nasal

1.7

92.4

2030

10832

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.9

92.2

179

261

K74

ICPC

Ischaemic heart dis with angina

32.0

92.2

L04AA06

ATC

mycophenolic acid; systemic

5.5

92.1

191

297

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

415.3

92.0

N05AA01

ATC

chlorpromazine; systemic, rectal

24.1

92.0

R04.2

ICD-10 Finland

Haemoptysis

3.9

91.8

291

644

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

33.4

91.8

I26

ICD-10 Finland

Pulmonary embolism

24.8

91.6

K93

ICPC

Pulmonary embolism

28.3

91.6

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

8.6

91.5

127

126

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

11.7

91.5

103

R35

ICD-10 Finland

Polyuria

2.5

91.4

617

2137

B03BA03

ATC

hydroxocobalamin; parenteral

2.9

91.4

455

1345

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

17.6

91.3

A07AA02

ATC

nystatin; oral

2.8

91.1

500

1559

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

91.0

2991

17698

C02DE04, ,

ATC

6.0

91.0

173

247

A10BX02

ATC

repaglinide; oral

806.8

90.8

R78

ICPC

Acute bronchitis/bronchiolitis

4.5

90.7

235

445

XQ800

NOMESCO Finland

Prick test

2.5

90.7

637

2248

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.5

90.7

625

2186

SPAT1312

SPAT

General health counselling

1.7

90.6

2423

13618

JN4AD

NOMESCO Finland

Body CT examination

2.2

90.5

891

3639

3A064, ,

NOMESCO Finland

50.8

90.1

R06AE07

ATC

cetirizine; oral

1.6

90.1

3628

22497

E87.6

ICD-10 Finland

Hypokalaemia

4.2

90.0

260

537

SPAT1260

SPAT

Consultation of another employee

1.9

89.9

1274

5943

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.3

89.7

250

502

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

8.3

89.5

128

132

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

19.5

89.5

N05AF01

ATC

flupentixol; systemic

8.1

89.4

130

137

5253

FHL

Cardiac lung machine

38.1

89.2

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

88.6

3208

19392

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

88.6

1128

5070

I20.9

ICD-10 Finland

Angina pectoris, unspecified

15.7

88.6

J34.2

ICD-10 Finland

Deviated nasal septum

2.5

88.6

595

2055

R03AC03

ATC

terbutaline; inhalant

2.0

88.4

1109

4958

RS230, ,

NOMESCO Finland

20.1

88.4

S76

ICPC

Skin infection other

2.9

88.1

463

1410

GD2SN

NOMESCO Finland

Lung ventilation SPECT

22.1

88.0

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.5

87.7

136

155

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

87.6

905

3764

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

121.5

87.5

100

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

87.5

322

791

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

87.4

656

2386

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

2.1

87.4

897

3722

F33

ICD-10 Finland

Recurrent depressive disorder

7.6

87.0

133

149

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

86.8

616

2183

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

45.4

86.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

86.7

2237

12436

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

10.2

86.6

106

M25.5

ICD-10 Finland

Pain in joint

1.6

86.2

2674

15561

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.6

86.2

219

408

A03FA02

ATC

cisapride; oral, rectal

2.5

86.1

585

2031

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

86.1

670

2477

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

85.9

EBA00

NOMESCO Finland

Extraction of tooth

1.6

85.6

2792

16442

W19

ICD-10 Finland

Unspecified fall

2.2

85.5

790

3143

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.1

85.4

377

1039

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.5

85.1

178

279

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.8

84.8

167

247

GD1UN

NOMESCO Finland

Lung circulation SPECT

26.6

84.7

Z01.2

ICD-10 Finland

Dental examination

1.5

84.5

3894

24778

H36.00

ICD-10 Finland

Diabetic background retinopathy

380.8

84.3

XF405

NOMESCO Finland

Symptom ECG

17.9

84.2

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

746.7

84.0

A10AD01

ATC

insulin (human); parenteral

134.6

83.9

C03BA11

ATC

indapamide; oral

4.3

83.8

233

467

T83

ICPC

Overweight

5.4

83.5

175

275

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

6.9

83.3

138

170

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.1

83.0

370

1025

RS222, ,

NOMESCO Finland

7.0

82.7

136

166

P29

ICPC

Psychological sympt/compl other

3.4

82.4

320

814

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

82.4

1857

9942

AA40B, ,

NOMESCO Finland

12.4

81.9

N06AX22

ATC

agomelatine; oral

7.5

81.8

127

145

TGC00

NOMESCO Finland

Bronchial lavation

3.8

81.6

271

620

C09DA03

ATC

valsartan and diuretics; oral

2.9

81.5

411

1223

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

367.9

81.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.7

81.4

276

641

P99

ICPC

Psychological disorders other

7.2

81.2

130

154

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

81.1

895

3813

B01AB04

ATC

dalteparin; parenteral

2.8

81.1

425

1292

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

721.0

81.1

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

81.0

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

80.7

432

1328

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.3

80.4

127

148

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

4.0

80.3

246

531

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

80.0

1021

4584

H3603, E103,

ICD-10 Finland

+∞

80.0

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

3.4

79.7

309

785

N05AB01

ATC

dixyrazine; systemic

11.6

79.6

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.4

79.5

103

R4180, ,

SPAT

14.6

79.4

F22.0

ICD-10 Finland

Delusional disorder

31.2

79.4

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.0

79.4

184

317

-42

ICPC

Electrical tracing

6.0

79.3

150

213

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.8

79.1

421

1290

R00.2

ICD-10 Finland

Palpitations

2.6

79.1

507

1710

FXG00

NOMESCO Finland

Insertion and use of IABP

703.9

79.1

ZXC60

NOMESCO Finland

Application of heat

4.2

79.1

226

463

H3603, E113,

ICD-10 Finland

+∞

79.0

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

11.9

78.9

XX3XW, ,

NOMESCO Finland

13.4

78.8

N05CF02

ATC

zolpidem; oral

1.8

78.6

1317

6463

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

4.7

78.6

194

353

R28

ICPC

Limited function/disability (R)

6.6

78.5

136

176

A77

ICPC

Viral disease other/NOS

3.3

78.4

312

806

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

126.0

78.2

I44.1

ICD-10 Finland

Atrioventricular block, second degree

6.5

78.1

136

177

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.7

78.0

265

616

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

77.6

529

1838

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

77.6

6224

44108

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.3

77.5

632

2382

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.2

77.4

328

881

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

147.8

77.4

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

77.4

588

2148

ZXA10

NOMESCO Finland

Bilateral

1.8

77.4

1514

7778

SPAT1059

SPAT

Spirometry at the office

2.9

77.3

396

1188

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.0

77.3

127

155

N17.8

ICD-10 Finland

Other acute renal failure

8.0

77.2

113

120

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

77.2

2031

11300

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

77.1

1322

6530

F40.1

ICD-10 Finland

Social phobias

9.1

77.0

102

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

8.8

76.8

105

102

F39

ICD-10 Finland

Unspecified mood [affective] disorder

9.7

76.4

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

8.7

76.3

105

103

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.5

76.3

500

1705

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

85.0

76.0

V03AE02

ATC

sevelamer; oral

20.4

76.0

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.6

75.9

264

624

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.8

75.8

246

554

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

75.7

951

4242

XA421

NOMESCO Finland

Nocturnal polygraphy

9.7

75.7

R4130

NOMESCO Finland

Speech therapy

3.9

75.6

239

528

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

75.4

912

4014

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

669.6

75.2

L14

ICPC

Leg/thigh symptom/complaint

2.3

75.2

654

2534

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

75.1

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

+∞

75.1

A10BX09

ATC

[U] dapagliflozin

+∞

75.1

E000001, ,

ATC

1.7

75.0

1570

8215

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.7

74.9

425

1347

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

5.9

74.9

144

208

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

176.2

74.8

J45.8

ICD-10 Finland

Mixed asthma

3.7

74.7

255

595

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

37.4

74.6

R13

ICD-10 Finland

Dysphagia

2.5

74.5

499

1719

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5.0

74.5

170

289

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

74.4

654

2544

CS494

NOMESCO Finland

Other visual field testing

3.4

74.4

281

702

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

4.3

74.3

202

398

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

230.0

74.2

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.4

74.2

157

249

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

74.0

3351

21079

XPX08

NOMESCO Finland

Intraoperative flow measurement

13.7

74.0

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.6

73.9

445

1455

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

73.6

5621

39236

M01AB05

ATC

diclofenac; systemic, rectal

1.5

73.3

6114

43406

FXZ00

NOMESCO Finland

Off-pump cardiac operation

652.5

73.3

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

652.5

73.3

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

34.5

73.2

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

73.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

72.8

276

691

A02BA04

ATC

nizatidine; systemic

2.3

72.7

588

2207

A02BC04

ATC

rabeprazole; oral

2.2

72.7

688

2758

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.2

72.7

310

836

JN4BD

NOMESCO Finland

Extensive body CT

1.9

72.6

974

4442

SPAT1058

SPAT

PEF monitoring instruction

2.3

72.5

586

2199

X58

ICD-10 Finland

Exposure to other specified factors

1.8

72.5

1203

5876

127

Kela drug reimbursment

Transplant complication

5.6

72.4

148

227

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

42.3

72.4

SPAT1360

SPAT

Extensive global examination

2.4

72.2

565

2090

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

72.2

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

72.2

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

+∞

72.2

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

72.2

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.5

72.1

479

1643

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.5

72.1

489

1694

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.4

72.1

278

704

B81

ICPC

Anaemia vit B12/folate deficiency

3.2

72.0

301

802

P74

ICPC

Anxiety disorder/anxiety state

4.5

72.0

189

362

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

72.0

3849

25011

SFA10

NOMESCO Finland

One-surface restoration

1.5

71.8

4563

30667

SPAT1053

SPAT

Memory test

1.9

71.8

1037

4847

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

17.8

71.7

N06AB08

ATC

fluvoxamine; oral

4.4

71.7

191

370

F31

ICD-10 Finland

Bipolar affective disorder

13.2

71.7

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.8

71.6

230

514

M03BX02

ATC

tizanidine; oral

1.5

71.6

5501

38347

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

71.5

715

2929

L16

ICPC

Ankle symptom/complaint

2.0

71.4

866

3813

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

9.9

71.4

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

10.3

71.2

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

71.2

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

71.2

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.5

71.2

184

348

315

Kela drug reimbursment

Clopidogrel

19.5

71.1

K08.3

ICD-10 Finland

Retained dental root

2.2

70.9

619

2400

-34

ICPC

Blood test

3.8

70.9

235

537

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

8.5

70.9

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

38.5

70.8

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

8.0

70.8

104

111

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.3

70.7

281

725

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

15.6

70.7

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

70.6

1351

6881

V03AA01, ,

ATC

7.0

70.6

115

139

J43.9

ICD-10 Finland

Emphysema, unspecified

5.7

70.1

140

210

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

69.9

2252

13114

D07AC01

ATC

betamethasone; topical

1.5

69.7

2978

18451

ZXD35

NOMESCO Finland

Usual procedure

3.2

69.7

299

809

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

15.2

69.7

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

8.4

69.6

F33.8

ICD-10 Finland

Other recurrent depressive disorders

26.9

69.5

S06.0

ICD-10 Finland

Concussion

2.1

69.5

737

3088

250, ,

Kela drug reimbursment

215.2

69.4

N18

ICPC

Paralysis/weakness

6.0

69.3

130

183

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

6.3

69.3

125

169

358

Kela drug reimbursment

liraglutide

+∞

69.3

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.9

69.3

132

189

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

23.7

69.2

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.0

69.1

332

961

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

9.6

68.8

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.4

68.7

182

351

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

111.8

68.7

A10BB07

ATC

glipizide; oral

97.0

68.6

X57

ICD-10 Finland

Unspecified privation

3.9

68.6

216

476

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

609.7

68.4

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.1

68.4

200

417

C07AA05

ATC

propranolol; systemic

1.7

68.4

1322

6749

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.5

68.4

2444

14561

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

+∞

68.3

DAX08

NOMESCO Finland

Fitting of hearing aid

2.4

68.1

501

1802

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

68.0

976

4549

D82

ICPC

Teeth/gum disease

1.5

67.8

3042

19016

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

67.4

162

288

M02AA07

ATC

piroxicam; topical

1.5

67.4

3067

19223

N30.0

ICD-10 Finland

Acute cystitis

1.8

67.3

1052

5037

FL1AC

NOMESCO Finland

Left cardioangiography

+∞

67.3

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

39.8

67.1

R4120, ,

SPAT

6.9

66.9

111

137

M01AB55

ATC

diclofenac, combinations; oral

2.3

66.8

548

2069

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.0

66.7

320

925

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

30.2

66.6

L90

ICPC

Osteoarthrosis of knee

2.2

66.6

586

2279

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

66.5

499

1811

SPAT1010

SPAT

Ophthalmoscopy

17.2

66.4

H3600, E103,

ICD-10 Finland

+∞

66.3

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

66.0

949

4423

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.7

65.8

222

514

A08AA02

ATC

fenfluramine; oral

8.2

65.7

1DC02, ,

NOMESCO Finland

13.4

65.4

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.9

65.2

207

459

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.5

65.1

167

314

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.8

64.8

337

1019

F20.9

ICD-10 Finland

Schizophrenia, unspecified

200.7

64.6

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.1

64.4

119

165

R33

ICD-10 Finland

Retention of urine

2.2

64.4

625

2528

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.1

64.4

120

168

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.2

64.4

267

708

K30

ICD-10 Finland

Functional dyspepsia

2.0

64.3

799

3544

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.5

64.2

237

583

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.3

64.2

542

2071

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

22.4

64.2

L60.0

ICD-10 Finland

Ingrowing nail

2.7

64.0

365

1160

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

63.8

403

1348

RS224, ,

NOMESCO Finland

12.4

63.7

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

63.6

1989

11467

WZC30

NOMESCO Finland

Teaching

1.7

63.4

1240

6341

SPAT1251

SPAT

Organisation of medication

3.8

63.3

204

457

XF612

NOMESCO Finland

Measurement of central venous pressure

16.7

63.3

K80

ICPC

Cardiac arrhythmia NOS

2.5

63.1

412

1401

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

79.6

63.0

I49.1

ICD-10 Finland

Atrial premature depolarization

4.3

62.9

175

351

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

12.2

62.9

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.6

62.9

223

534

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.9

62.9

199

440

N18

ICD-10 Finland

Chronic kidney disease

7.5

62.9

110

N05AH02

ATC

clozapine; systemic

24.9

62.7

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

62.6

697

2971

F05.9

ICD-10 Finland

Delirium, unspecified

5.5

62.4

128

197

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

62.4

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

8.1

62.3

C09CA07

ATC

telmisartan; oral

2.1

62.2

637

2630

C10AB02

ATC

bezafibrate; oral

7.9

62.2

P20

ICPC

Memory disturbance

1.9

62.2

915

4293

M01AX17

ATC

nimesulide; oral

1.6

62.1

2001

11609

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

6.5

61.9

108

141

AQ1

Conventional electrophysiological examination

37.2

61.8

ACC51

NOMESCO Finland

Release of median nerve

2.1

61.7

626

2576

WX213

NOMESCO Finland

Lower leg blockade

8.9

61.7

SFA30

NOMESCO Finland

Three-surface restoration

1.4

61.7

3663

24080

A10BD15

ATC

metformin and dapagliflozin; oral

549.8

61.6

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

61.5

692

2961

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.5

61.4

126

194

5315

FHL

Bypass surgery using a mammary artery

+∞

61.4

N06AA06

ATC

trimipramine; systemic

4.1

61.4

177

365

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

61.3

432

1523

C10AA02

ATC

lovastatin; oral

3.2

61.1

263

713

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

12.8

61.0

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.5

61.0

159

303

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.6

60.9

368

1204

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

8.5

60.9

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

6.2

60.8

111

152

WX144

NOMESCO Finland

Subconjunctival anesthesy

5.8

60.8

119

175

SPAT1172

SPAT

Guidance concerning hydration

3.9

60.8

187

405

M01AH02

ATC

rofecoxib; oral

1.8

60.6

1028

5039

E87.2

ICD-10 Finland

Acidosis

25.4

60.6

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

144.1

60.5

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

60.5

G04CB01

ATC

finasteride; oral

1.9

60.4

906

4276

N06AA04

ATC

clomipramine; systemic

6.0

60.3

113

159

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

60.2

464

1703

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

60.2

1680

9416

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

326

196

14.45

323.31

2.0

2.1

106.46

93.72

ug/min

0.16

200

104

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8561

56432

2.99

318.94

9.3

3.1

42.96

36.59

mmol/mol

307.65

7871

51435

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

825

1611

4.61

310.60

1.9

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1374

3877

3.30

309.20

2.3

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4604

20973

2.58

307.65

5.9

4.4

34.38

36.15

g/l

68.14

4302

19374

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1962

5292

3.64

307.65

3.3

2.0

30.71

29.00

25.27

1919

5177

(3001604) Monocytes [#/volume] in Blood

5651

27060

2.76

307.65

7.9

5.8

0.66

0.57

e9/l

86.74

4925

23173

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1548

3272

4.53

307.65

10.1

5.7

5.33

5.16

kpa

5.74

1465

3157

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4537

19680

2.73

307.65

3.8

2.2

174.25

149.93

ug/l

1.14

4110

18255

(3019198) Lymphocytes [#/volume] in Blood

5772

27950

2.76

307.65

8.0

5.8

1.94

1.98

e9/l

0.61

5196

24455

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3633

12295

3.34

307.65

2.5

1.7

201.99

204.64

u/l

0.05

3449

11410

(3019225) pH of Specimen

2291

5247

4.48

307.65

4.6

3.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1808

3124

5.73

307.65

11.1

6.4

11.37

8.17

mmol/l

46.42

1693

2999

(3009508) Creatinine [Moles/volume] in Urine

4155

9148

5.85

307.65

4.0

2.1

8.20

8.33

mmol/l

0.85

3170

7846

(3013512) EKG study

4860

14369

4.61

307.65

5.2

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

7211

43161

2.48

307.65

5.3

3.5

14.93

10.46

mm/h

90.05

6600

39605

(3009343) pH of Capillary blood

2855

2392

13.69

307.65

4.6

4.5

7.42

7.43

0.40

237

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

788

894

7.97

307.65

1.7

1.2

—

(3006315) Basophils [#/volume] in Blood

5674

27105

2.78

307.65

7.9

5.8

0.04

e9/l

0.92

4948

23184

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

788

894

7.97

307.65

1.7

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3735

15395

2.67

307.65

3.2

3.0

38.37

32.48

u/l

2.22

3526

14688

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2362

5139

4.76

307.65

8.6

5.4

1.08

1.03

mmol/l

8.07

2189

4786

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2790

9569

3.02

307.65

2.5

1.6

1.32

1.10

mg/l

2.24

2120

7408

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

731

1065

6.16

307.65

3.2

2.0

423.68

376.12

ug/l

0.22

700

983

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2779

2323

13.59

307.65

4.6

4.5

1.31

1.23

mmol/l

0.45

2208

1681

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5757

24832

3.26

307.65

10.9

5.4

1.22

1.23

mmol/l

27.39

5247

21003

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1304

3117

3.90

307.65

5.7

3.5

110.01

73.21

ng/l

27.57

1166

2732

(4146454) Self-monitoring of blood glucose

488

44.04

307.65

2.7

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

1241

2747

4.20

307.65

5.9

4.3

5.09

4.72

kpa

4.64

1173

2671

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3503

14664

2.56

307.65

2.8

2.3

56.54

68.64

u/l

1.69

3204

13513

(3019069) Monocytes/100 leukocytes in Blood

5850

25788

3.21

307.65

8.4

6.2

8.56

8.74

4.03

5429

24177

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4395

8425

7.08

307.65

4.0

1.7

1878.36

453.84

ng/l

59.55

3500

6741

(3018010) Neutrophils/100 leukocytes in Blood

5908

26250

3.20

307.65

7.9

5.8

59.38

55.38

105.34

5495

24659

(3044640) Blood type and Crossmatch panel - Blood

4471

17186

3.16

307.65

3.1

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7670

44488

2.97

307.65

9.8

6.8

83.26

79.06

u/l

9.96

7163

41676

(3037467) Urinalysis macro (dipstick) panel - Urine

6774

38708

2.48

307.65

5.5

3.4

—

(3022096) Basophils/100 leukocytes in Blood

5685

24797

3.17

307.65

8.1

6.0

0.61

0.71

36.86

5244

23144

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

939

1500

5.72

307.65

1.9

1.6

1.64

1.50

g/l

3.07

818

1269

(40760892) CBC W Ordered Manual Differential panel - Blood

5238

25478

2.54

307.65

7.9

6.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5884

26382

3.15

307.65

7.0

6.5

12.51

12.09

umol/l

1.00

5585

25090

(3026782) Osmolality of Urine

2900

10026

3.03

307.65

3.8

2.5

562.57

571.27

mosm/kgh2o

1.13

2595

8570

(3013650) Neutrophils [#/volume] in Blood by Automated count

5915

32282

2.34

307.65

10.6

9.0

4.59

3.79

e9/l

104.21

5127

27890

(3006504) Eosinophils/100 leukocytes in Blood

5825

25629

3.21

307.65

8.0

6.0

2.78

3.01

11.16

5384

23982

(3052851) Hemolysis interference index of Serum or Plasma

793

1369

5.21

307.65

5.3

2.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1329

3252

3.82

307.65

11.9

6.2

1.37

1.23

mmol/l

4.93

1273

3160

(3013826) Glucose [Moles/volume] in Serum or Plasma

6422

27553

3.72

307.65

6.6

3.2

7.03

6.11

mmol/l

177.45

6050

25777

(3027945) Reticulocytes/100 erythrocytes in Blood

1665

4691

3.39

307.65

2.7

2.8

1.88

1.58

22.69

1454

4197

(3003396) Base excess in Arterial blood by calculation

1538

3276

4.49

307.65

10.1

5.6

1.12

0.63

mmol/l

3.54

1295

2679

(3000991) Gas panel - Venous blood

1500

3361

4.25

307.65

13.8

7.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4539

21978

2.36

307.65

2.8

2.0

76.41

79.86

nmol/l

12.00

3855

19762

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1180

2183

5.03

307.65

1.9

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

362

79.05

307.65

3.7

2.4

0.81

0.87

nmol/l

—

296

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2153

4853

4.49

307.65

3.7

2.1

20.28

25.57

49.87

2039

4312

(3002032) Base excess in Venous blood by calculation

1544

3286

4.50

307.65

7.0

4.5

2.14

1.79

mmol/l

2.46

1347

2780

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2582

8888

2.95

307.65

3.9

2.7

2.89

1.87

e6/l

5.05

1701

4662

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5418

22503

3.26

307.65

9.8

4.9

1.22

mmol/l

10.91

4833

20256

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1747

5228

3.20

307.65

4.1

5.4

250.74

245.16

u/l

0.66

1630

5007

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2372

6481

3.73

307.65

5.8

2.0

1026.78

89.33

ng/l

1.84

2045

4481

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

918

627

13.48

307.65

4.0

2.8

0.29

0.33

u/ml

1.20

552

258

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4578

15385

3.79

307.65

4.4

1.9

52.49

18.89

ng/l

6.24

3465

9080

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2257

5196

4.44

307.65

3.5

2.0

2.34

2.29

g/l

2.84

2082

4804

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3352

7278

5.34

307.65

5.4

3.6

29.66

31.63

19.91

2640

4462

(3002030) Lymphocytes/100 leukocytes in Blood

5949

26673

3.18

307.65

8.2

6.0

25.69

29.49

108.18

5533

25061

(3033658) Prothrombin time (PT) actual/Normal

3292

13637

2.54

307.65

6.7

3.4

82.33

95.22

124.47

3243

13361

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2864

2409

13.65

307.65

4.7

4.5

5.21

5.03

kpa

20.64

2699

2289

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1540

3285

4.49

307.65

7.0

4.5

6.03

5.77

kpa

12.81

1480

3213

(3027801) Oxygen [Partial pressure] in Arterial blood

1548

3270

4.54

307.65

10.0

5.7

10.58

14.22

kpa

112.51

1455

3156

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2230

6013

3.74

307.65

2.3

1.6

—

(3023368) Bacteria identified in Blood by Culture

3750

11677

3.74

307.65

6.0

3.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1361

1884

6.89

307.65

10.6

7.6

24.85

24.24

mmol/l

6.69

1298

1846

(3026493) Urate [Moles/volume] in Serum or Plasma

3572

14129

2.76

307.65

3.5

2.2

6880.84

4635.26

umol/l

1.67

2989

12649

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

271

103

22.75

307.65

1.1

58.54

9.17

iu/ml

0.67

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

389

158

21.54

307.65

2.1

1.4

1.06

0.78

nmol/l

3.44

300

146

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2681

6301

4.54

307.65

4.8

3.9

0.82

0.83

mmol/l

4.50

2507

5882

(3019309) Folate [Moles/volume] in Red Blood Cells

2695

7330

3.87

307.65

1.9

1.6

792.15

1141.93

nmol/l

91.03

2030

5346

(3042936) Bacteria identified in Isolate by Culture

2044

6537

3.06

307.65

2.6

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7021

41995

2.39

307.65

4.4

3.4

14.80

14.69

pmol/l

2.80

6260

37762

(3022217) INR in Platelet poor plasma by Coagulation assay

5599

18989

4.39

307.65

21.1

4.0

1.46

1.07

inr

43.06

634

5442

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

901

1780

4.59

307.65

2.1

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3144

9627

3.56

307.65

2.7

1.9

3.47

2.77

mg/l

29.29

2607

8013

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6815

39682

2.42

307.65

4.3

2.4

63.91

42.81

u/l

48.02

6336

36992

(3022313) Gas panel - Capillary blood

2685

1878

16.12

307.65

4.4

4.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3697

13111

3.19

307.65

2.9

2.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2861

10054

2.96

307.65

1.7

1.4

19.75

21.24

nmol/l

4.56

2348

8301

(3016502) Oxygen saturation in Arterial blood

1196

2809

3.94

307.65

11.3

6.2

93.51

96.39

26.56

1160

2735

(3020682) Albumin/Creatinine [Ratio] in Urine

4338

8701

6.67

307.65

4.7

2.2

15.97

7.02

mg/mmol

1.57

2852

4531

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1068

2021

4.86

307.65

2.2

1.5

10.86

3.97

ug/l

8.90

845

1669

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8488

53707

3.26

307.65

5.9

3.7

2.21

2.26

mu/l

0.07

7632

48370

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2507

1754

15.75

307.65

4.6

4.8

24.92

24.39

mmol/l

12.53

2362

1647

(3013115) Eosinophils [#/volume] in Blood

5892

28086

2.88

307.65

8.3

5.9

0.20

0.19

e9/l

3.02

5191

24302

(3012516) Albumin [Mass/volume] in Urine

3916

8240

5.95

307.65

4.0

2.0

119.78

768.55

mg/l

12.80

2648

4310

(3022948) Iron [Moles/volume] in Serum or Plasma

2363

5760

4.22

307.65

3.5

2.0

12.08

18.11

umol/l

1.06

2235

5385

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1257

1988

5.95

307.65

3.7

1.6

469.32

82.47

ng/l

50.76

1162

1749

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5508

18349

4.42

307.65

2.4

1.6

98.89

97.90

pmol/l

0.65

3132

8902

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1105

1945

5.26

307.65

7.4

5.8

24.52

24.09

mmol/l

3.11

1078

1929

(3007853) Bacteria identified in Skin by Aerobe culture

1645

5232

2.97

302.04

2.3

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6226

36118

2.21

297.03

5.6

3.4

3418.06

1423.86

e6/l

0.46

541

(40758558) Short blood count panel - Blood

3203

14421

2.28

285.31

8.9

7.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1081

2775

3.56

280.51

1.8

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

514

712

6.36

279.64

4.1

3.6

24.91

24.51

mmol/l

1.29

508

700

(40768797) Stomach Pathology biopsy report

1730

5895

2.78

278.27

1.3

1.2

—

(4200892) Spirometry reversibility

1220

3410

3.29

277.26

1.5

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

3486

16530

2.19

270.90

4.8

2.8

49.19

78.26

e6/l

1.34

2870

12293

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3923

19539

2.14

268.50

4.8

2.8

—

0.37

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1304

3900

3.09

264.33

2.4

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4726

25420

2.08

262.11

3.2

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1242

3631

3.15

261.49

2.1

2.8

340.20

365.56

nmol/l

4.16

1116

3417

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1616

5486

2.77

260.50

3.1

3.0

8.32

8.80

umol/l

0.39

1466

4863

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1391

4366

2.96

258.93

2.4

0.21

0.22

g/l

4.22

1288

4142

(3019060) Gas panel - Arterial blood

691

1357

4.53

257.35

2.7

2.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1237

3691

3.08

251.10

2.3

3.0

65.98

67.19

g/l

5.16

1093

3382

(3026008) Bacteria identified in Urine by Culture

2958

13478

2.21

250.02

3.4

2.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

666

1300

4.55

249.75

1.6

1.5

8.46

11.35

iu/ml

0.37

(3018095) Leukocytes [#/volume] in Urine

3824

19469

2.06

240.26

5.8

3.2

60.43

77.84

e6/l

1.49

2974

13307

(3037121) Protein [Mass/volume] in Urine

782

1794

3.90

237.43

3.4

4.0

0.40

0.22

g/l

4.23

334

897

(3023183) Ammonium ion [Moles/volume] in Plasma

430

587

6.40

236.84

2.6

34.62

36.12

umol/l

0.55

382

520

(3024928) Oxygen saturation in Venous blood

433

597

6.34

236.25

4.1

5.5

—

(3000034) Microalbumin [Mass/volume] in Urine

283

229

10.68

235.57

3.7

1.8

34.05

24.67

mg/l

0.42

206

135

(3023520) Reticulocytes [#/volume] in Blood

1144

3389

3.08

234.35

2.4

2.9

72.94

65.10

e9/l

7.34

828

2478

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8898

62643

2.86

231.39

25.8

9.3

24.02

25.11

mg/l

2.25

7979

45461

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

691

1490

4.12

227.94

14.0

7.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

652

1400

4.13

216.06

1.5

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

828

2113

3.51

214.94

1.8

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

407

583

6.09

213.86

2.2

1.8

23.94

26.49

mg/l

0.34

124

146

(3036489) Thrombin time

627

1328

4.18

211.47

3.2

2.5

22.21

21.10

3.57

593

1176

(3022689) Creatine [Moles/volume] in Urine

167

24.22

207.75

1.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1018

3056

3.01

202.60

2.1

2.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

819

2172

3.37

199.98

15.1

7.3

0.54

0.68

18.60

813

2164

(3030467) Casts [#/volume] in Urine by Automated count

3048

15106

2.01

197.88

4.7

2.8

0.56

0.34

e6/l

5.46

2445

11042

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

548

1101

4.38

197.56

3.6

3.1

214.86

177.60

13.79

528

1043

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

548

1127

4.27

191.72

3.5

3.1

3.91

3.46

g/l

5.98

521

1077

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2148

9439

2.17

191.32

3.8

2.5

1.05

1.06

e6/l

0.02

1262

5192

(3019550) Sodium [Moles/volume] in Serum or Plasma

9087

66115

2.82

189.35

29.8

9.3

139.74

139.90

mmol/l

8.30

8865

63831

(3004119) Hemoglobin [Mass/volume] in Venous blood

708

1786

3.52

186.38

5.0

3.6

130.15

130.80

g/l

0.27

695

1763

(3023103) Potassium [Moles/volume] in Serum or Plasma

9104

66468

2.81

184.62

30.3

9.4

4.00

3.96

mmol/l

38.04

8859

64013

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

512

1032

4.35

183.66

1.4

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

792

2178

3.24

182.05

15.3

7.2

1.29

1.25

0.49

785

2169

(3007164) IgA [Mass/volume] in Serum or Plasma

2153

9650

2.12

181.10

1.6

1.4

2.61

2.33

g/l

3.92

1261

5832

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

562

1247

3.96

177.66

3.5

2.8

90.66

93.04

1.40

551

1192

(3028308) Erythrocytes [#/volume] in Pleural fluid

302

384

6.80

177.31

1.5

1.4

52163.67

59427.68

e6/l

0.14

219

238

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

137

26.57

175.83

2.3

1.4

155.55

14.79

ug/min

1.57

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1465

5674

2.38

174.86

2.0

1.4

1.51

1.29

23.37

1227

5142

(3023199) Leukocytes [#/volume] in Pleural fluid

309

414

6.45

172.89

1.5

1.4

2622.84

3512.36

e6/l

0.29

232

296

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

682

1768

3.41

171.91

2.2

2.3

3.92

3.68

g/l

1.58

606

1602

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

682

1771

3.41

171.45

2.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

682

1774

3.40

170.99

2.2

2.3

7.66

7.12

g/l

10.20

607

1609

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8612

61831

2.29

169.84

23.0

8.9

77.42

81.64

ml/min/173m2

56.87

7884

49576

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

310

430

6.23

167.81

7.8

5.3

10.92

10.86

mg/l

0.08

279

396

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

654

1683

3.43

166.63

2.2

2.4

3.14

2.90

g/l

5.81

577

1517

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

583

1398

3.67

165.06

2.5

2.4

—

(3012441) Differential panel - Pleural fluid

288

380

6.54

163.41

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

610

1520

3.53

163.15

2.3

2.5

0.90

0.92

g/l

0.04

530

1319

(3037522) Nuclear Ab [Titer] in Serum

1617

6732

2.22

162.01

1.4

1.3

455.30

549.93

titre

1.52

345

1370

(3005988) Vibrio sp identified in Specimen by Organism specific culture

345

551

5.43

161.93

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

707

1946

3.22

161.80

1.6

1.7

11.23

13.81

u/ml

0.23

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

344

551

5.41

160.96

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

563

1346

3.67

160.01

2.4

2.3

0.04

0.03

g/l

0.30

506

1257

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

180

131

11.77

159.97

2.2

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

342

548

5.41

159.95

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

306

440

6.01

159.92

1.5

1.3

30.48

39.03

g/l

17.64

245

412

(3024522) Salmonella sp identified in Specimen by Organism specific culture

343

553

5.37

159.36

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

344

564

5.28

156.95

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

340

554

5.32

156.17

1.4

—

(3000494) Fungus identified in Specimen by Culture

1536

6363

2.22

155.25

1.8

1.3

—

(3045788) Cell count panel - Pleural fluid

253

312

6.98

152.57

1.6

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

457

981

4.06

150.75

1.7

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1934

8858

2.04

150.31

1.6

1.5

402.66

36289666.74

pmol/l

8.71

1535

7330

(3038515) Glucose [Moles/volume] in Venous blood

377

699

4.68

149.54

4.6

2.2

7.57

6.39

mmol/l

15.64

371

693

(3008037) Lactate [Moles/volume] in Venous blood

381

731

4.52

144.99

4.6

2.2

1.59

1.39

mmol/l

3.68

375

718

(3017732) Neutrophils [#/volume] in Blood

1070

3901

2.47

144.24

3.3

2.4

4.38

4.45

e9/l

0.11

765

3217

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1216

4718

2.33

142.71

3.1

2.3

36.32

55.98

u/l

1.56

1030

4150

(3051611) Lipemic interference index of Serum or Plasma

307

499

5.31

141.32

5.3

2.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

398

811

4.26

140.44

1.7

1.5

—

(3045424) Erythrocytes [Presence] in Urine

425

912

4.05

140.17

1.7

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

284

433

5.66

139.85

3.5

3.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

543

1399

3.40

137.65

2.3

35.90

38.84

g/l

19.29

466

1230

(3005719) IgG [Mass/volume] in Serum or Plasma

985

3537

2.49

136.84

2.9

2.8

10.34

10.46

g/l

0.33

903

3248

(3030981) Hyaline casts [#/volume] in Urine by Automated count

844

2812

2.67

136.60

3.4

2.4

0.22

0.23

e6/l

0.12

831

2727

(3015377) Calcium [Moles/volume] in Serum or Plasma

3268

18238

1.76

135.40

3.3

3.9

2.35

2.36

mmol/l

2.44

2577

16097

(36304419) Bacteria [Presence] in Urine

2769

14798

1.80

132.46

4.7

2.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

818

2740

2.65

130.83

1.9

2.0

1.22

1.38

g/l

1.20

726

2518

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8436

61624

2.01

130.60

5.6

3.2

1.56

1.23

mmol/l

209.21

7631

56098

(1761482) Bacteria [#/volume] in Urine by Culture

483

1195

3.53

130.15

4.0

3.0

—

(3000850) Epithelial cells [#/volume] in Urine

2176

10861

1.88

129.28

3.4

2.3

5.30

4.86

e6/l

0.90

1931

9680

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8480

62170

2.01

127.94

6.6

3.3

6.35

5.55

mmol/l

307.65

7484

56501

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

585

1657

3.10

127.05

2.2

2.3

10.46

10.28

g/l

0.37

505

1488

(3016244) Insulin [Units/volume] in Serum or Plasma

193

218

7.58

125.43

3.2

3.0

45.85

16.87

mu/l

9.49

186

207

(3023419) Bacteria identified in Sputum by Culture

291

502

5.00

125.38

3.0

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

411

939

3.80

124.28

1.5

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

486

1245

3.40

124.13

2.4

0.00

g/l

0.50

430

1160

(3028707) Methadone [Presence] in Urine by Screen method

162

149

9.29

123.37

3.1

2.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

480

1233

3.39

122.06

2.4

0.00

g/l

-0.00

430

1157

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

558

1576

3.10

121.69

1.5

1.6

228.00

305.62

titre

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

493

1294

3.32

121.19

2.7

3.8

52.80

45.59

mg/l

0.32

451

1085

(3044927) Protein electrophoresis panel - Urine

259

415

5.37

121.01

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

493

1299

3.31

120.44

2.7

3.8

77.82

40.59

mg/l

2.06

450

1082

(3021589) Normoblasts [#/volume] in Blood

4224

25889

1.65

119.59

11.2

8.0

0.00

e9/l

0.48

3379

21048

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

479

1259

3.32

117.44

2.7

3.8

5.94

2.20

ratio

0.36

113

(3004616) Nuclear Ab [Presence] in Serum

312

615

4.38

114.69

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

847

3095

2.43

112.51

1.4

1.3

219.00

272.87

u/ml

1.03

795

2890

(40768806) Pleura Pathology biopsy report

249

412

5.19

112.35

1.4

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

25.20

112.29

14.6

6.7

5.50

5.07

mmol/l

0.46

(40761511) CBC panel - Blood by Automated count

8943

67579

2.13

111.04

22.0

8.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

32.74

110.49

1.2

1.8

1.40

1.41

nmol/l

0.02

(3000570) Elastase.pancreatic [Mass/mass] in Stool

440

1141

3.35

110.13

1.5

1.3

262.57

280.32

ug/g

0.88

264

659

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

220

331

5.70

109.77

3.1

2.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

171

202

7.24

107.01

1.1

4.23

8.12

u/ml

0.81

(3028626) Oxygen [Partial pressure] in Capillary blood

448

1205

3.23

105.74

11.4

5.8

8.32

9.05

kpa

12.77

438

1175

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

624

2028

2.70

105.31

2.5

1.9

37.67

41.02

u/l

3.56

525

1857

(3051593) INR in Capillary blood by Coagulation assay

18.37

104.13

3.1

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

355

828

3.71

104.12

4.0

2.3

1.54

1.48

0.32

346

783

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

388

964

3.49

103.68

1.4

1.9

—

(3051651) Icteric interference index of Serum or Plasma

189

265

6.10

101.15

6.9

3.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

492

1447

2.96

99.79

5.4

2.7

25.49

25.39

mmol/l

0.28

481

1420

(3017143) Hepatitis C virus Ab [Presence] in Serum

1164

5091

2.05

99.26

1.8

1.5

—

(3000492) Spirometry study

1262

5707

1.99

98.00

1.8

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

280

574

4.20

97.88

3.1

3.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4146

26165

1.57

97.54

5.0

4.7

2.42

3.35

ug/l

2.56

3542

24102

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

135

136

8.46

96.11

2.5

2.3

—

(40768804) Tissue Pathology biopsy report

4203

26674

1.57

95.99

2.2

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

225

398

4.85

94.17

2.9

1.8

—

(3014271) Vancomycin [Susceptibility]

145

165

7.49

93.66

2.9

2.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2021

10763

1.73

92.67

1.3

1.2

2.25

2.22

u/ml

0.03

329

2915

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

427

1211

3.06

92.17

2.8

2.0

13.55

10.35

mg/l

10.72

389

1141

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

329

809

3.51

89.23

1.3

1.2

111.43

130.00

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

263

552

4.09

89.14

1.4

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

458

1381

2.88

88.73

7.3

3.2

47.39

48.14

0.24

449

1363

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

702

2615

2.36

88.73

2.8

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

189

303

5.33

88.24

1.3

7.05

5.11

mmol/l

8.78

170

272

(3000330) Specific gravity of Urine by Test strip

683

2524

2.37

87.87

3.9

2.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8507

64263

1.79

87.48

6.2

3.5

1.29

1.54

mmol/l

307.65

7704

58980

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

438

1308

2.90

86.33

2.0

1.7

1.10

2.31

ug/l

1.52

370

1160

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

144

179

6.86

86.20

1.4

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

144

179

6.86

86.20

1.4

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

243

493

4.23

86.08

1.7

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1775

9287

1.74

85.92

1.3

1.2

40.44

42.77

iu/ml

0.14

457

3152

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9112

70503

2.05

84.77

15.3

7.9

31.35

25.82

u/l

28.88

8753

67544

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

209

382

4.68

84.19

1.2

1.3

138.13

182.38

titre

0.39

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8661

65945

1.82

84.05

6.4

3.8

2.59

3.09

mmol/l

307.65

7833

60308

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

422

1257

2.91

83.53

1.7

1.5

0.25

0.23

g/l

2.95

388

1193

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

682

2575

2.32

83.46

3.0

3.6

4.35

4.56

pmol/l

5.41

589

2319

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

208

382

4.66

83.32

1.2

1.3

60.00

50.00

titre

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8542

64816

1.78

83.20

6.1

3.5

4.42

5.05

mmol/l

307.65

7897

59655

(3034770) Mitochondria Ab [Titer] in Serum

384

1097

3.03

81.79

1.2

1.3

1686.25

929.81

titre

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

193

339

4.87

81.44

6.4

3.4

351.36

378.19

umol/l

1.29

165

273

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

189

326

4.96

81.42

2.0

1.7

—

(3037756) Immunofixation for Serum or Plasma

336

889

3.26

81.30

1.6

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1212

5737

1.89

81.26

1.8

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

181

301

5.14

81.22

1.3

963.01

562.44

u/l

0.47

169

287

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

224

447

4.29

81.04

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

426

1300

2.84

80.68

1.7

1.5

1.24

1.16

g/l

5.55

394

1240

(3048689) Calprotectin [Mass/mass] in Stool

1288

6230

1.85

80.68

2.2

2.5

156.71

135.85

ug/g

0.85

959

5005

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

279

660

3.63

80.11

2.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

279

660

3.63

80.11

2.0

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

314

806

3.35

79.71

4.1

2.3

0.72

0.85

10.53

307

760

(3045414) Leukocytes [Presence] in Urine

650

2452

2.32

79.62

1.8

1.7

—

(36660697) Celiac disease serology panel - Serum

899

3897

2.04

77.64

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

379

1115

2.94

76.65

1.2

1.3

67.27

207.25

titre

1.35

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

183

324

4.83

76.52

2.1

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

270

652

3.56

75.21

1.3

1.4

41.67

35.66

u/l

0.19

219

556

(46235355) HIV 1 and 2 tests - Meaningful Use set

1378

6947

1.78

74.94

1.9

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

342

961

3.07

74.90

2.7

3.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

300

782

3.30

74.32

3.0

3.4

1.64

1.69

0.06

264

695

(3000093) Morphology [Interpretation] in Blood Narrative

205

413

4.25

73.28

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

145

218

5.67

72.43

1.4

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

26.34

71.62

2.8

1.4

48.25

37.72

umol/l

1.04

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

146

224

5.56

71.43

1.5

—

(3021901) Oxygen saturation in Capillary blood

228

516

3.78

69.75

4.3

3.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

15.34

69.11

1.4

1.2

201.53

98.71

ng/l

0.92

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

286

759

3.24

68.84

2.0

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

327

943

2.99

68.47

9.1

4.5

951.75

2865.47

iu/ml

0.45

111

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

405

1314

2.66

68.20

1.5

—

(3042733) HLA Ab [Presence] in Serum

8.78

67.54

5.3

4.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

12.38

67.17

12.4

8.1

0.59

0.55

mmol/l

0.41

(3036180) Methadone [Presence] in Urine

13.60

66.91

1.8

1.2

—

(3005570) Glucose [Moles/volume] in Urine

206

447

3.94

66.80

1.7

1.6

—

14.20

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1619

8795

1.66

66.42

1.3

1.2

17.29

14.94

u/ml

0.39

417

3524

(3049717) Cytology report of Urine Cyto stain

548

2076

2.29

66.25

2.5

2.9

—

(40761536) Microorganisms panel - Urine sediment

131

4402

0.24

66.21

4.5

3.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

223

517

3.69

65.93

1.4

1.2

4.90

4.06

u/ml

0.41

238

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

220

507

3.71

65.61

1.2

1.4

23.87

33.98

u/l

3.92

175

417

(3022145) Colonoscopy Study observation

1304

6707

1.73

65.48

1.4

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

272

723

3.23

65.31

4.9

3.3

552.92

17729.16

u/ml

0.82

(3000475) Leukocytes [#/volume] in Synovial fluid

391

1282

2.63

64.47

1.6

19456.39

10607.90

e6/l

2.11

300

925

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

448

1570

2.47

64.41

6.7

5.5

1.72

1.23

mg/l

21.76

409

1470

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

476

1717

2.40

64.28

1.6

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

187

391

4.09

63.73

1.2

2.60

52.91

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

990

4768

1.83

61.93

1.6

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

183

386

4.05

61.65

1.2

91.71

105.24

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

177

365

4.14

61.43

1.1

1.2

6.10

2.98

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

183

388

4.03

61.23

1.2

72.09

34.29

u/ml

0.82

(3003181) Sodium [Moles/volume] in Urine

235

594

3.39

61.10

1.5

1.6

68.86

66.34

mmol/l

0.29

180

468

(3021440) Promyelocytes/100 leukocytes in Blood

873

4069

1.88

60.49

4.7

4.0

0.04

0.10

3.26

370

1202

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

391

1329

2.54

59.92

1.4

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

143

255

4.78

59.35

1.2

1.3

15.07

16.70

u/l

0.27

134

248

(3017354) Segmented neutrophils/100 leukocytes in Blood

207

492

3.60

59.05

3.0

3.6

59.28

54.28

2.34

180

409

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

377

1269

2.56

58.93

1.2

6.71

6.20

u/ml

0.07

207

(3003338) MCHC [Mass/volume]

5998

57279

0.70

58.77

32.9

11.4

329.93

333.52

g/l

113.73

5936

56841

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

308

937

2.82

58.59

2.0

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.20

58.55

1.8

1.3

140.64

72.47

umol/l

0.67

(3021879) Hepatitis B virus core Ab [Presence] in Serum

785

3575

1.92

58.28

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

126

204

5.25

58.27

1.8

2.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

325

1023

2.73

58.00

1.2

1.60

5.58

u/ml

0.91

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

300

906

2.84

57.84

2.0

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

371

1253

2.55

57.59

1.2

2.66

7.77

u/ml

0.65

129

(3020876) Protein [Mass/time] in 24 hour Urine

176

381

3.94

57.28

2.0

2.7

1.17

1.08

g/24h

0.15

192

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

186

5.44

57.14

1.3

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

226

584

3.31

56.78

1.1

1.54

1.45

g/l

2.44

192

545

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

123

200

5.23

56.63

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

123

200

5.23

56.63

1.8

2.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

205

500

3.50

56.29

1.2

1.1

116.11

118.35

0.32

197

438

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

136

244

4.74

56.06

1.8

1.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

27.97

55.95

9.0

7.5

67.74

37.00

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

136

245

4.73

55.80

1.8

1.9

—

(3017181) Myelocytes/100 leukocytes in Blood

877

4215

1.82

54.95

4.8

4.0

0.76

0.96

1.57

372

1348

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

387

1365

2.44

54.82

1.2

76.97

39.84

u/ml

0.72

105

(3006184) Hemoglobin [Mass/volume] in Capillary blood

274

812

2.89

54.67

1.8

1.7

136.60

132.75

g/l

1.07

139

542

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

387

1369

2.44

54.48

1.5

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

8.71

54.11

1.2

1.3

255.63

348.37

pmol/l

0.63

(3020491) Glucose [Moles/volume] in Blood

149

302

4.20

52.92

1.5

1.3

8.24

5.99

mmol/l

4.87

213

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

395

1430

2.38

52.84

1.4

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

211

547

3.30

52.76

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

8.85

51.81

1.2

1.3

61.53

53.07

mu/l

0.16

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1135

5970

1.68

51.69

2.7

2.0

12.08

13.89

nmol/l

12.51

984

5536

(3051101) Glucose [Moles/volume] in Cord blood

21.39

51.11

3.2

1.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

140

278

4.29

51.05

1.0

1.1

281.67

285.05

mg/l

0.21

117

268

(3026250) Tacrolimus [Mass/volume] in Blood

133

6.06

51.01

40.6

35.9

6.91

6.88

ug/l

0.05

117

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

173

5.30

50.56

2.3

2.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

256

766

2.86

50.21

1.5

0.65

0.91

g/l

3.18

223

594

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

302

992

2.61

49.59

1.8

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

160

362

3.77

49.04

1.2

1.5

—

titre

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

362

1304

2.39

48.96

1.4

1.5

8.30

8.81

u/l

0.31

285

1019

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

199

525

3.24

48.41

1.2

1.3

0.11

0.19

nmol/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

200

542

3.15

46.58

1.4

1.2

3.15

4.50

u/ml

0.47

195

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

197

530

3.17

46.44

1.2

1.3

0.58

2.76

nmol/l

0.51

182

512

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

189

496

3.25

46.38

1.2

53.93

70.01

u/l

2.10

179

438

(3010375) cycloSPORINE [Mass/volume] in Blood

109

193

4.80

45.68

36.1

26.5

128.28

117.71

ug/l

0.66

172

(21494755) Public health laboratory ask at order entry panel

533

8147

0.53

44.97

1.4

—

(3025159) Blasts/100 leukocytes in Blood

785

3868

1.77

44.96

4.9

4.0

0.03

0.50

2.15

288

1008

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

292

997

2.51

44.32

1.8

1.4

20.05

9.55

u/ml

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

148

345

3.65

43.51

1.2

2.12

1.95

mmol/l

0.96

139

332

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

208

603

2.95

43.21

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

158

5.10

42.74

1.9

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

218

653

2.85

42.71

1.3

1.2

7.67

6.53

mmol/l

5.78

179

559

(3025941) Bacteria identified in Stool by Culture

609

2823

1.87

42.52

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

173

455

3.24

42.34

1.2

1.3

—

nmol/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

226

695

2.78

42.19

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1164

14335

0.64

42.12

3.5

3.2

0.00

estimate

1.24

297

4678

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2312

14767

1.41

41.97

1.6

1.5

1.60

1.27

mmol/l

40.95

2063

12422

(3002179) Metamyelocytes/100 leukocytes in Blood

768

3846

1.74

41.48

3.8

3.9

0.73

0.65

0.38

361

1159

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

820

4195

1.70

40.99

2.5

2.4

17.46

22.43

au/ml

0.83

416

(3022493) Free Hemoglobin [Mass/volume] in Plasma

158

4.99

40.88

12.4

1.4

59.20

2478.73

mg/l

0.77

112

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

145

349

3.54

40.70

2.5

3.0

0.26

0.24

e9/l

0.37

129

282

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

178

490

3.10

40.44

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

141

5.23

40.28

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

7.70

39.92

1.7

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2527

16510

1.39

39.81

3.2

2.9

0.79

0.78

ug/l

0.13

1620

10280

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

151

379

3.39

39.79

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

143

5.16

39.67

1.9

1.1

—

(3018418) pH of Serum or Plasma

2287

14701

1.40

39.65

6.9

3.7

7.40

0.02

101

2627

(3006462) Nitrate [Presence] in Urine

106

207

4.35

39.55

3.9

2.3

—

(3011288) Drugs identified in Urine by Screen method

182

515

3.01

39.46

3.9

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

244

4.04

39.34

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

136

321

3.60

39.30

2.4

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

147

367

3.41

39.07

2.5

2.9

589.29

537.20

e6/l

0.33

131

291

(21494890) Protein electrophoresis panel - 24 hour Urine

158

415

3.24

38.78

1.7

2.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

678

3350

1.76

38.30

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

489

2183

1.93

38.22

2.0

1.6

34.74

42.16

nmol/l

13.43

465

2144

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

365

1469

2.13

37.92

2.1

1.8

197.74

215.69

pmol/l

2.69

340

1419

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

110

229

4.08

37.83

1.3

—

(3021788) Differential panel - Synovial fluid

280

1010

2.37

37.78

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

144

364

3.37

37.56

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

144

364

3.37

37.56

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

144

364

3.37

37.56

1.8

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

525

2414

1.88

37.52

2.2

1.4

4.74

2.94

mg/l

3.54

469

1582

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

327

1287

2.18

35.95

1.1

5.43

6.93

u/ml

0.31

217

(3048929) Epstein Barr virus Ab [Presence] in Serum

343

1378

2.14

35.80

1.5

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

140

360

3.31

35.57

2.5

2.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

267

972

2.35

35.30

1.5

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

253

906

2.39

34.71

2.1

1.9

5.15

5.59

mmol/24h

1.22

221

806

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

118

277

3.62

34.42

1.2

1.3

39.91

17.79

u/l

3.14

108

228

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

120

285

3.58

34.42

1.2

1.3

116.91

72.91

u/l

3.45

112

243

(40768446) Kidney Pathology biopsy report

177

4.36

34.17

2.1

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

458

2.95

33.49

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

155

440

3.00

33.48

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

386

1664

1.99

33.36

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

727

3803

1.66

33.22

1.4

1.3

68.44

59.44

au/ml

0.39

270

(4062490) Immunoglobulin typing, IgG

160

465

2.93

33.18

1.5

1.3

—

(3035880) pH of Pleural fluid

161

4.48

32.98

1.2

—

(3011985) Renin [Units/volume] in Plasma

176

541

2.77

32.96

1.3

1.6

96.62

67.31

mu/l

0.57

151

484

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

149

419

3.02

32.72

2.1

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

149

419

3.02

32.72

2.1

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

218

751

2.48

32.55

2.5

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.81

32.35

1.3

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

249

915

2.32

32.26

1.9

1.4

102.74

110.24

u/ml

0.41

169

(3004775) Volume in Urine collected for unspecified duration

6.21

32.05

2.3

2.2

691.28

681.60

0.05

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

164

496

2.81

31.67

2.1

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

121

306

3.36

31.60

1.4

1.5

13.80

11.52

umol/l

2.77

116

301

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5192

38498

1.28

31.28

2.9

2.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1559

9723

1.42

31.21

3.2

3.4

2.47

2.45

mmol/l

8.34

1219

8648

(3022621) pH of Urine by Test strip

667

3473

1.66

30.98

3.1

2.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.66

30.66

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

162

4.29

30.24

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

173

4.16

30.18

2.3

3.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

137

386

3.02

30.02

1.4

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

113

285

3.37

29.66

1.2

1.3

28.57

251.43

titre

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

154

467

2.80

29.62

1.3

2.49

3.07

g/l

3.24

138

327

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

162

505

2.73

29.59

1.3

1.5

274.31

374.46

pmol/l

1.03

142

447

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.00

29.56

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

5.52

29.52

1.6

2.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

9.77

29.41

2.0

2.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

7.46

29.25

1.4

7.87

431120.07

nmol/l

1.06

(3024139) IgG subclass 3 [Mass/volume] in Serum

153

467

2.79

29.08

1.3

0.33

0.41

g/l

2.64

135

329

(3027135) IgG subclass 1 [Mass/volume] in Serum

153

467

2.79

29.08

1.3

7.05

6.82

g/l

0.20

131

329

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

601

7962

0.61

28.96

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

157

4.26

28.93

2.5

1.5

4776.57

2243.71

u/ml

—

(3006270) Folate [Moles/volume] in Blood

130

366

3.02

28.55

1.2

1.1

346.75

374.05

nmol/l

0.66

102

328

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

161

518

2.64

27.69

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1116

6682

1.46

27.65

5.1

4.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.62

27.59

2.8

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

177

599

2.52

27.49

1.5

2.3

626.67

2417.78

titre

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

175

589

2.53

27.49

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

508

2.65

27.22

1.7

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

9242

74875

1.56

27.11

36.2

13.3

40.30

41.35

1.42

9053

70607

(4034850) Laboratory test

1819

0.25

27.11

3.9

6.3

—

(3011412) CD3 cells [#/volume] in Blood

157

505

2.64

27.03

2.4

2.8

1.44

1.21

e9/l

1.56

141

440

(3016038) Potassium [Moles/volume] in Urine

240

3.46

26.94

1.3

1.5

35.02

38.77

mmol/l

0.67

208

(3007461) Platelets [#/volume] in Blood

9244

74931

1.55

26.56

35.8

13.2

248.55

250.16

e9/l

1.46

9040

72104

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

180

629

2.44

26.15

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

169

574

2.50

26.08

2.5

2.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

229

894

2.18

25.77

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

231

905

2.18

25.77

1.5

1.3

273.72

253.13

u/ml

0.52

154

559

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

257

3.30

25.55

1.2

1.1

—

(3035941) MCH [Entitic mass]

9246

75018

1.54

25.54

35.7

13.2

30.16

30.38

26.49

9111

73570

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

112

309

3.08

25.50

1.3

1.5

31.43

20.10

u/ml

0.50

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

8.01

25.49

2.0

2.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

602

2.45

25.37

1.7

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

221

3.49

25.36

1.1

3.67

3.12

iu/ml

—

(3010813) Leukocytes [#/volume] in Blood

9249

75060

1.54

25.35

35.9

13.2

7.32

6.35

e9/l

176.86

8998

71965

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

6.83

25.34

1.1

—

(3024731) MCV [Entitic volume]

9246

75039

1.53

25.22

35.7

13.2

90.94

90.88

0.57

9113

73585

(3026361) Erythrocytes [#/volume] in Blood

9246

75049

1.53

25.07

35.8

13.2

4.51

4.58

e12/l

25.48

8994

71973

(40757373) Influenza virus identified in Isolate

6.93

25.07

2.2

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

343

1566

1.87

25.06

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

147

477

2.62

24.91

2.4

2.6

782.23

680.72

e6/l

1.17

142

465

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

594

3172

1.61

24.89

1.2

121.11

166.16

iu/ml

2.02

183

1193

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

122

359

2.88

24.85

2.5

2.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

9247

75085

1.53

24.68

36.0

13.3

135.00

138.48

g/l

74.85

9114

73637

(40768443) Skin Pathology biopsy report

520

2693

1.66

24.61

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.45

24.11

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

530

2779

1.64

23.89

1.1

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1032

6267

1.43

23.52

3.2

4.6

22.19

23.44

ug/l

0.04

853

5041

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

283

1240

1.95

23.41

1.5

674.01

519.38

mg/l

0.87

263

1193

(3024932) HLA-DR beta [Type]

140

4.05

23.07

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.59

22.83

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

176

3.66

22.74

1.2

1.3

192.20

157.60

mmol/24h

1.40

176

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

157

552

2.42

22.57

2.1

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.85

22.37

1.1

—

(3048879) Bone marrow aspiration report

151

3.87

22.35

1.3

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

255

3.12

22.07

1.5

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

255

3.12

22.07

1.5

1.7

—

(3016879) Cocaine [Presence] in Urine

252

1084

1.98

22.00

2.6

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

+∞

21.44

1.2

0.0

101.92

—

ug/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

278

2.99

21.35

1.6

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

299

1377

1.85

21.31

2.9

2.2

—

(1002224) Polysomnography panel

489

2586

1.62

21.31

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1847

0.34

21.16

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

177

3.54

21.16

2.6

2.4

51.52

51.59

umol/l

0.01

165

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

124

4.09

20.99

1.1

5.37

10.92

u/ml

0.85

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.17

20.99

1.6

1.5

1.61

1.40

mg/l

0.09

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.17

20.99

1.6

1.5

0.67

0.95

mg/l

0.30

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.17

20.99

1.6

1.5

1.04

2.63

mg/l

0.85

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.17

20.99

1.6

1.5

0.39

1.36

mg/l

2.44

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.17

20.99

1.6

1.5

2.60

3.41

mg/l

0.27

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

4.19

20.93

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2057

0.37

20.86

1.6

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

121

4.12

20.85

1.6

0.37

0.36

ug/l

0.03

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

114

4.23

20.80

1.2

1.1

—

(3024471) HLA-A [Type]

148

3.77

20.70

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

151

543

2.36

20.69

1.8

1.4

34.56

22.00

iu/ml

—

(1616796) Gas panel - Central venous blood

171

651

2.23

20.54

4.6

2.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

112

4.23

20.44

1.3

1.1

—

(4035726) Immunohistochemistry procedure

997

6164

1.40

20.41

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.33

20.35

1.2

1.1

—

(3034426) Prothrombin time (PT)

109

4.27

20.31

1.4

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

191

766

2.12

20.18

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

4.15

19.99

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.19

19.94

8.2

6.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

9.14

19.74

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

119

4.05

19.70

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

238

1044

1.94

19.69

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.93

19.59

1.7

2.9

16.12

19.94

umol/l

0.79

(3003327) Ova and parasites identified in Stool by Light microscopy

355

1765

1.72

19.58

1.8

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

281

1312

1.83

19.20

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

8.78

19.18

1.8

1.3

—

(40762814) Titanium [Mass/volume] in Blood

107

4.19

19.14

2.2

2.3

4.72

4.19

ug/l

0.12

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

4.11

19.06

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

302

2.78

18.99

4.0

2.4

8.10

6.25

mmol/l

4.65

257

(3044941) Cell count panel - Synovial fluid

195

813

2.04

18.63

1.5

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

169

669

2.15

18.49

1.6

—

(3008295) Osmolality of Serum or Plasma

108

350

2.62

18.47

1.6

1.4

282.61

279.52

mosm/kgh2o

0.47

288

(3000764) Benzodiazepines [Presence] in Urine

261

1207

1.84

18.41

2.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

2617

25670

0.81

18.24

3.4

2.3

—

(3014891) Appearance of Pleural fluid

7.60

17.85

1.3

—

(3001556) Androgen free Index in Serum or Plasma

20.72

17.75

2.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

152

588

2.20

17.63

1.5

1.7

—

(3047189) Immunofixation for 24 hour Urine

226

3.00

17.63

1.7

2.1

—

(3024263) Appearance of Synovial fluid

272

2.80

17.60

1.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

237

1079

1.87

17.57

1.5

1.6

3.93

3.48

mmol/l

7.10

220

1038

(3028300) Cannabinoids [Presence] in Urine

262

1232

1.81

17.53

2.6

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

325

1629

1.70

17.44

1.7

1.6

0.04

1.27

iu/ml

0.59

322

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

8.11

17.40

5.6

13.3

—

(3027008) Opiates [Presence] in Urine

261

1229

1.81

17.39

2.5

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

5.33

17.22

1.2

0.70

0.64

umol/24h

0.19

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

105

4.03

17.19

1.3

343.21

260.12

ug/l

0.16

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

124

3.75

17.18

2.1

1.4

17499.49

10979.95

e6/l

0.30

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.37

17.18

1.2

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

3.96

17.13

1.3

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

140

3.50

16.45

2.3

1.4

16929.10

5101.86

e6/l

0.40

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.79

16.18

5.8

13.3

—

(3023410) Appearance of Cerebral spinal fluid

144

567

2.16

16.03

1.8

2.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

15.19

16.02

1.3

1.0

43.11

38.30

mg/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

100

3.97

15.91

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

156

637

2.08

15.83

1.7

1.6

58.12

55.99

0.25

109

384

(3020717) Zinc [Moles/volume] in Serum or Plasma

241

2.81

15.78

1.7

17.71

30.08

umol/l

3.60

234

(3008536) Aspergillus sp Ab [Presence] in Serum

101

3.93

15.70

2.0

2.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

469

2.26

15.66

1.4

137986.22

73260.91

e6/l

0.44

333

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

128

486

2.23

15.59

2.8

3.1

18.54

17.42

nmol/l

0.59

115

474

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.76

15.52

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

5.76

15.52

1.7

2.9

1.06

1.68

mmol/l

0.79

(3002256) Pathology report gross observation

1298

8697

1.30

15.36

1.3

—

(3010503) CD19 cells [#/volume] in Blood

324

2.51

15.20

2.1

2.9

0.17

0.46

e9/l

0.69

319

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

207

2.90

14.88

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

129

3.47

14.88

2.3

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

6.98

14.81

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

279

2.61

14.77

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.59

14.68

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

103

3.77

14.56

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

202

930

1.85

14.54

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.19

14.54

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

272

2.61

14.49

1.0

1.1

2.33

11.88

nmol/l

0.88

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

283

2.57

14.37

1.1

—

(3017704) Immunofixation for Urine

180

3.01

14.29

1.4

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

301

2.50

14.07

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.34

14.06

1.5

1.2

71.33

82.67

0.39

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

238

2.70

14.00

1.1

1.2

17.87

16.99

u/l

0.11

212

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

231

1121

1.75

13.99

1.7

1.9

3.58

4.76

iu/l

1.60

434

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

328

2.43

13.92

1.5

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

239

2.69

13.89

1.1

1.2

83.78

76.24

u/l

0.52

215

(3044242) Glucose [Moles/volume] in Arterial blood

119

3.48

13.83

1.3

2.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

264

2.60

13.81

1.2

1.4

5.35

5.78

u/l

0.44

225

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

410

5042

0.67

13.60

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

159

3.08

13.54

2.3

2.5

171.17

126.44

2.67

149

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.49

13.46

1.3

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

6957

55408

1.19

13.41

31.5

11.2

18.12

14.68

163.91

6857

54135

(3014765) Yersinia sp identified in Stool by Organism specific culture

281

1461

1.64

13.21

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

250

1268

1.68

12.94

3.8

2.5

24.14

28.34

mg/l

0.93

120

752

(3020911) Cortisol [Moles/time] in 24 hour Urine

104

3.57

12.94

1.4

80.25

205.47

nmol/24h

0.66

104

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

10.55

12.79

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

281

1475

1.62

12.73

1.2

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

350

4378

0.66

12.65

4.1

2.2

57.98

70.91

ml/min/173m2

6.84

166

1495

(3019897) Erythrocyte distribution width [Ratio] by Automated count

819

0.24

12.54

2.4

2.0

13.18

13.13

0.17

803

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

193

920

1.78

12.47

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

14.76

12.47

1.3

1.0

—

(3027944) Amphetamines [Presence] in Urine

240

1220

1.67

12.34

2.5

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.05

12.22

1.5

1.2

81.94

89.46

0.24

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

193

929

1.76

12.08

1.7

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

208

1025

1.72

12.00

1.2

48.04

45.13

u/ml

0.08

102

(3045142) Bone marrow Pathology biopsy report

160

729

1.86

11.99

1.3

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

181

2.80

11.91

3.1

2.5

253.33

319.29

e6/l

0.47

(40767503) Oxygen content in Capillary blood by calculation

145

641

1.92

11.91

2.8

1.9

17.33

16.93

0.65

118

322

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.73

11.90

1.4

1.1

31.83

25.34

g/l

1.43

(3050794) Legionella sp Ab [Presence] in Serum

5.27

11.87

1.2

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

16.03

11.67

1.1

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

312

3925

0.66

11.61

4.3

3.3

1.23

mmol/l

0.51

296

3329

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

272

1451

1.59

11.57

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

171

2.82

11.45

1.3

1.2

40.38

40.06

g/l

0.04

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

126

3.15

11.44

1.1

109.60

111.34

0.15

117

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

143

640

1.89

11.34

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.71

11.19

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

374

2.17

11.12

1.3

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.07

11.09

4.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

223

2.54

11.04

2.7

3.9

1.50

1.45

ug/l

0.06

217

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1058

0.38

10.88

3.8

3.5

60.31

56.41

1.43

1058

(3047007) Chlamydophila sp Ab [Presence] in Serum

184

902

1.73

10.86

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

352

2.19

10.75

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

10.72

4.8

0.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1011

0.37

10.65

3.7

3.3

4.65

3.78

e9/l

2.24

1011

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

133

2.99

10.49

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2212

21178

0.85

10.46

3.9

2.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

707

7628

0.76

10.40

1.9

1.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

143

2.89

10.37

1.1

1.2

0.33

0.30

g/l

1.26

119

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

341

2.18

10.36

1.4

1.3

1.26

4.12

u/ml

2.28

198

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.43

10.33

1.9

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

113

3.14

10.20

2.2

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

111

474

1.98

10.14

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

379

2.10

10.03

1.2

64.95

44.61

mg/l

0.49

316

(21494434) Karyotype in Bone marrow

113

488

1.96

10.01

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

128

2.97

9.97

1.7

1.6

2.04

3.78

nmol/l

0.58

107

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

161

783

1.74

9.82

3.3

2.9

1207.13

396.43

u/ml

0.33

161

771

(3011436) Histone Ab [Units/volume] in Serum

3.44

9.80

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

233

2.39

9.66

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.40

9.63

1.5

1.1

19.20

12.99

g/l

3.18

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

140

2.84

9.62

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.48

9.43

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

119

535

1.88

9.39

1.1

1.3

—

(3015736) pH of Urine

2860

21648

1.16

9.32

3.3

2.7

5.73

5.87

1.48

212

2204

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

101

431

1.98

9.29

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

3554

27336

1.15

9.23

3.6

2.9

0.00

estimate

0.46

406

5049

(3009261) Glucose [Presence] in Urine by Test strip

3612

27815

1.15

9.22

3.7

2.9

0.00

estimate

-0.00

276

4874

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.06

9.18

1.3

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

11.03

9.08

1.2

1.1

284.00

119.83

pmol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.43

8.84

1.6

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

11.24

8.65

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1409

0.53

8.38

1.2

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

147

731

1.70

8.35

2.0

2.3

1389.59

4083.37

u/l

0.95

269

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

342

2058

1.41

8.24

3.2

3.9

1934.44

1557.77

u/ml

0.08

299

1780

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.16

8.19

1.5

1.4

121.67

94.29

ng/l

0.37

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

763

0.37

8.14

1.3

1.5

—

(3022670) pH of Venous cord blood

4.56

8.14

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

107

2.92

8.03

1.3

1.2

79.16

88.66

0.70

(3044007) Cell count panel - Peritoneal fluid

121

2.79

8.02

2.5

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

361

1.99

7.99

2.6

2.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

157

805

1.65

7.98

1.1

5.96

4.01

u/ml

0.45

424

(3018133) Calcium [Moles/volume] in Urine

141

2.63

7.92

3.5

3.0

2.47

2.81

mmol/l

0.55

129

(3025018) Bordetella pertussis Ab [Titer] in Serum

399

1.93

7.82

1.3

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.58

7.78

1.1

19.09

23.33

u/l

0.48

(3033086) Enterovirus NOS Ab [Titer] in Serum

13.70

7.72

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

258

1496

1.46

7.62

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1293

9316

1.19

7.59

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

266

0.16

7.50

1.6

1.5

—

(40768441) Liver Pathology biopsy report

423

1.88

7.49

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

202

2.30

7.47

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

104

484

1.82

7.46

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

395

1.91

7.40

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

395

1.91

7.40

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

395

1.91

7.40

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

216

1216

1.51

7.39

1.2

1.1

2.09

1.85

u/ml

0.11

110

665

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.28

7.38

1.2

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

209

1169

1.52

7.38

1.4

1.8

305.91

256.70

mu/l

1.87

199

1091

(3042111) Morphology [Interpretation] in Bone marrow Narrative

163

863

1.60

7.33

1.5

1.7

—

(3042517) Benzodiazepines panel - Urine

18.54

7.30

3.1

2.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

104

2.84

7.28

1.4

1.2

66.47

90.98

2.29

(3044889) 12 lead EKG panel

5169

41110

1.12

7.25

4.3

2.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

392

1.90

7.25

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

392

1.90

7.25

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

392

1.90

7.25

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

254

2.13

7.24

1.2

1.1

—

(3019977) pH of Arterial blood

124

2.65

7.16

2.0

7.41

7.42

0.56

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

101

2.84

7.08

1.4

1.5

19.39

14.86

pmol/l

0.57

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

302

2.01

7.05

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.71

6.95

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.34

6.93

1.1

—

(3019174) dRVVT (LA screen)

6.07

6.90

1.2

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

3536

27561

1.12

6.90

6.0

3.9

0.00

estimate

-0.00

311

4787

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

260

2.08

6.84

2.0

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

151

807

1.58

6.57

1.5

1.3

118.12

188.25

pmol/l

12.34

151

807

(3003888) Timothy IgE Ab [Units/volume] in Serum

197

1117

1.49

6.57

1.1

3.29

4.04

u/ml

0.42

635

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.34

6.56

1.3

1.2

267.82

388.97

umol/24h

1.22

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

13.25

6.52

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

4.10

6.48

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

141

2.45

6.47

1.1

22.88

14.17

u/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.03

6.41

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.75

6.41

4.4

6.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

112

2.64

6.39

1.0

1.4

126.14

135.90

nmol/l

0.15

(3044009) aPTT.lupus sensitive (LA screen)

5.42

6.37

1.2

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

9.20

6.05

5.8

8.2

0.23

0.13

mmol/l

0.62

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.31

5.96

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

358

0.23

5.89

1.3

1.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

153

2.32

5.89

1.1

1.2

1.30

8.28

u/ml

0.70

141

(3034274) Bile acid [Moles/volume] in Serum --fasting

318

1.89

5.84

2.0

3.4

8.15

16.90

umol/l

1.69

241

(3029075) Extractable nuclear Ab panel - Serum

134

2.39

5.73

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

188

1088

1.46

5.72

1.1

0.71

0.97

u/ml

0.35

530

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

144

789

1.54

5.69

3.4

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

138

749

1.56

5.69

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

208

1235

1.43

5.54

2.9

3.7

165.86

256.29

u/ml

0.62

195

1124

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

313

1.86

5.48

1.4

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

225

1358

1.40

5.47

5.4

4.5

24.82

24.67

mmol/l

0.22

218

1303

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

186

1087

1.45

5.41

1.7

3865.17

1208.88

e6/l

0.37

153

861

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

186

1087

1.45

5.41

1.6

37.08

12.86

e6/l

0.91

140

819

(3009015) Lactate [Moles/volume] in Synovial fluid

3.09

5.35

1.5

1.2

5.45

7.43

mmol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

316

1.84

5.34

1.4

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

372

1.75

5.02

1.0

788.70

671.59

ng/l

1.61

258

(3025577) Chromium [Mass/volume] in Blood

366

1.75

5.01

2.1

2.0

2.42

2.40

ug/l

0.02

318

(3012494) Peanut IgE Ab [Units/volume] in Serum

204

2.03

5.01

1.2

6.19

17.33

u/ml

0.42

151

(3038177) Helicobacter pylori Ab [Presence] in Serum

158

909

1.47

5.01

1.4

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

373

1.74

4.98

2.5

1.8

3.08

2.62

u/field

0.14

165

(3028717) Thiamine [Mass/volume] in Blood

5.77

4.98

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.12

4.96

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

374

1.74

4.94

1.0

49.78

43.76

ng/l

0.61

269

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.85

4.91

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

542

3750

1.23

4.88

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

145

2.21

4.85

1.5

12.25

8.62

ug/l

2.47

145

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

371

1.73

4.80

1.0

335.46

368.97

ng/l

0.40

272

(3047352) Trisomy 18 risk [Likelihood] in Fetus

352

0.31

4.76

1.1

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

130

2.27

4.76

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

310

1.80

4.75

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

136

2.23

4.71

1.4

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

148

2.17

4.63

1.8

1.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.61

4.62

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

382

1.70

4.61

2.1

2.0

4.31

3.21

ug/l

0.61

361

(3030313) Adrenal Ab [Titer] in Serum

4.72

4.59

1.2

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

166

983

1.43

4.56

1.1

24.85

10.25

au/ml

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.62

4.55

1.3

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

364

0.35

4.44

1.1

1.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

4.54

4.44

1.1

1.3

—

(3005033) Fetal Nuchal fold Thickness US

350

0.34

4.41

1.1

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

409

2778

1.25

4.40

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

487

3374

1.23

4.37

1.8

1.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.37

4.31

1.2

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

153

2.10

4.29

2.8

3.2

27.86

27.97

umol/l

0.02

124

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.42

4.28

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.77

4.28

3.6

3.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

443

1.62

4.26

1.1

9.11

10.79

iu/ml

0.17

(3009871) Measles virus Ab [Titer] in Serum

195

1.95

4.18

1.6

1.8

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.72

4.17

1.3

1.5

15.00

18.86

nmol/l

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.45

4.14

3.4

2.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

11.80

4.13

1.3

1.2

2.21

2.40

mmol/24h

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

263

1.80

4.09

1.2

1.1

1558.68

299.07

ng/l

0.58

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

469

1.59

4.04

2.1

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

8.42

4.03

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2736

21522

1.10

3.99

3.6

3.9

21.83

21.02

1.92

1236

10506

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.99

3.96

1.0

1.1

0.08

0.16

u/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.81

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.81

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

138

820

1.42

3.80

1.1

6.25

5.48

u/ml

0.13

336

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.81

3.79

1.0

1.1

0.21

0.84

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

264

1.76

3.77

1.1

1.74

1.09

u/l

0.44

141

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

111

2.20

3.74

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

162

1.98

3.73

1.1

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

271

1.74

3.73

1.5

1.2

—

(40765096) Chromosome analysis panel by Banding

187

1.90

3.65

1.3

1.2

—

(3008898) HLA-B27 [Presence]

263

1738

1.28

3.62

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.71

3.57

3.1

3.0

16.71

4.10

—

(3004451) EKG impression Narrative

2.55

3.55

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

169

0.25

3.55

1.0

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

369

2543

1.23

3.55

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

418

0.46

3.52

1.1

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

649

0.57

3.49

1.3

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

449

0.49

3.45

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

146

1669

0.73

3.42

2.0

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

492

0.51

3.41

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

122

2.07

3.37

1.3

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

420

0.48

3.32

1.1

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

420

0.48

3.32

1.1

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

446

1.53

3.30

1.3

1.9

6.21

3.30

mg/l

2.93

431

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

418

0.48

3.28

1.1

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

359

2494

1.22

3.23

1.1

182.50

273.11

titre

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.95

3.22

1.1

1.3

1.58

1.30

1.68

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

233

1.74

3.22

1.0

19.10

19.74

mmol/l

0.55

227

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

333

0.43

3.20

1.5

1.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.61

3.18

1.0

—

(3003694) ABO and Rh group [Type] in Blood

2115

16595

1.09

3.18

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

101

588

1.45

3.17

1.5

1.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.53

3.16

1.1

0.07

0.95

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.53

3.16

1.1

1.2

0.07

2.61

u/ml

0.91

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

456

0.52

3.15

1.1

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

6.55

3.14

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.21

3.14

10.5

7.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

100

583

1.45

3.12

1.4

1.3

0.16

0.29

nmol/l

3.04

412

(3004959) Base excess in Arterial cord blood by calculation

224

1.73

3.06

1.0

-0.01

-1.75

mmol/l

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

224

1.73

3.06

1.0

7.81

7.10

kpa

1.48

191

(3006598) pH of Arterial cord blood

224

1.73

3.06

1.0

—

(40758292) HTLV I+II Ab panel - Serum

111

2.05

2.98

1.4

1.5

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

7.22

2.90

1.3

1.0

2190.00

2532.86

titre

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.83

2.89

3.4

14.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.83

2.89

1.0

1.5

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

222

1.71

2.88

1.0

2.97

3.37

kpa

1.27

190

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.47

2.87

1.0

1.85

0.01

u/ml

1.05

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

185

1.78

2.86

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.13

2.81

1.4

1.3

74.23

59.95

1.41

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.66

2.78

1.1

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

113

1296

0.73

2.78

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.43

2.77

1.1

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

138

1.89

2.77

1.3

1.4

15.11

14.89

u/ml

0.01

110

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

6.32

2.70

1.0

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.06

2.69

1.6

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

2.74

2.66

2.4

1.6

510.38

111.73

umol/l

0.62

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.04

2.65

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.04

2.65

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.04

2.65

1.4

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

162

1053

1.30

2.64

1.1

0.83

2.12

u/ml

3.18

548

(40758358) Immune stain study

2.97

2.60

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

282

1.59

2.58

1.4

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.37

2.57

1.4

2.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.09

2.53

6.8

5.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.89

2.52

1.1

2.27

1.48

umol/24h

0.75

(3014133) Dog dander IgE Ab [Units/volume] in Serum

135

862

1.32

2.52

1.1

3.82

4.54

u/ml

0.24

416

(3027035) Albumin [Mass/time] in 24 hour Urine

3.61

2.52

1.1

1.2

—

166.76

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.43

2.47

1.7

1.5

75.94

33.46

pmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.99

2.44

1.4

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.99

2.44

6.8

5.5

—

(42870560) Thyrotropin [Units/volume] in Cord blood

287

1.56

2.42

1.0

11.31

8.45

mu/l

1.34

256

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.45

2.41

18.0

7.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.12

2.37

1.3

1.1

—

(3008607) Semen analysis panel

2.90

2.36

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.55

2.35

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

539

0.62

2.34

1.3

1.38

1.57

g/l

3.65

539

(3041096) Erythrocytes [Presence] in Urine by Automated

1883

14893

1.08

2.31

3.9

2.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

111

1.90

2.30

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

116

737

1.33

2.27

1.1

0.54

0.19

u/ml

0.74

224

(3005011) Chlamydia sp Ab [Titer] in Serum

1.97

2.25

1.3

1.5

—

(40768800) Prostate Pathology biopsy report

207

2130

0.81

2.24

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.93

2.21

1.0

—

(3016135) IgD [Mass/volume] in Serum

4.60

2.20

1.2

1.1

258.15

32.56

mg/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.05

2.17

1.5

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.26

2.14

3.3

2.3

—

(3019150) Specific gravity of Urine by Refractometry

1204

10944

0.92

2.14

3.4

3.2

1.02

kg/l

0.56

267

1636

(3020891) Body temperature

107

1183

0.76

2.13

4.6

3.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

184

1.65

2.11

1.1

1.2

1.05

ratio

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

1.81

2.10

1.2

1.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.26

2.08

4.2

4.8

450.00

374.38

umol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

212

1.59

2.04

1.3

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

136

0.37

2.04

7.3

5.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

137

0.37

2.03

3.7

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.92

2.03

1.7

3.5

—

(3001729) Color of Synovial fluid

2.33

1.99

1.2

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

657

4987

1.12

1.98

3.7

2.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

195

1.60

1.95

1.9

1.8

9.82

10.34

mg/l

0.27

161

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

118

1.79

1.95

1.2

—

(3015183) Erythrocyte sedimentation rate

313

0.56

1.89

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.93

1.87

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.21

1.79

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.83

1.71

1.7

1.5

184.33

148.21

titre

—

(3039443) Prostate specific Ag panel - Serum or Plasma

232

2294

0.85

1.71

1.7

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.98

1.71

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

190

1.55

1.67

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

279

1.45

1.67

1.6

1.7

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.83

1.67

1.2

1.0

594.40

625.00

u/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

533

1.31

1.61

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

172

1206

1.20

1.58

1.3

154.81

215.96

miu/ml

1.28

609

(40761539) Cells [Type] in Urine sediment by Light microscopy

114

1.70

1.57

1.4

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

332

3171

0.88

1.56

1.8

1.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.51

1.55

1.0

0.01

0.04

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

168

1.56

1.51

1.3

1.2

—

(4212803) Bone marrow aspirate examination

2.11

1.50

1.2

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.81

1.50

1.9

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

1.59

1.45

1.3

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.24

1.45

1.0

0.02

0.03

u/ml

—

(3009677) Dengue virus Ab [Presence] in Serum

2.81

1.45

1.0

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

270

1.41

1.37

1.7

1.8

3.04

3.32

u/field

0.06

192

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.66

1.37

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

161

1.52

1.31

1.6

2.2

29.77

40.37

u/l

0.31

147

(3017509) Phencyclidine [Presence] in Urine

2.41

1.30

1.9

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.53

1.29

1.2

1.0

—

(44813793) Dust mix specific IgE antibody measurement

360

1.34

1.29

1.3

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

262

1941

1.14

1.28

1.4

25.39

34.80

iu/l

4.93

214

1646

(3013637) Mi-2 Ab [Presence] in Serum

102

1.65

1.27

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

102

1.65

1.27

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

102

1.65

1.27

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

102

1.65

1.27

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

204

1.45

1.26

3.1

3.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.84

1.26

1.2

1.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.25

1.24

1.3

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.91

1.19

1.3

2.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.63

1.19

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

214

1.42

1.18

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.11

1.17

1.0

1.1

—

(3013762) Body weight Measured

0.00

1.17

0.0

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

1.13

3.6

3.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.76

1.11

1.7

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.76

1.11

1.7

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.27

1.10

1.1

1.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.71

1.09

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

164

0.56

1.09

1.0

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

384

0.72

1.06

4.8

7.3

—

(3000012) Reticulocyte production index

524

1.24

1.04

1.6

2.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

171

0.59

1.02

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.98

0.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

505

0.78

0.91

1.8

1.5

27.78

35.74

0.79

294

(3016750) Collection duration of Urine

1.64

0.90

2.6

2.4

474.14

486.69

min

0.22

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.87

0.87

1.0

1.1

—

23.07

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.02

0.87

1.2

1.0

9.00

25.24

u/l

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

603

0.81

0.86

1.8

1.4

0.95

0.98

g/l

0.34

603

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.58

0.85

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

327

0.75

0.82

1.6

2.8

41.23

37.46

—

130

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

239

1.30

0.80

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

199

0.68

0.79

1.9

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

181

1.35

0.79

3.1

3.2

54.06

130.66

umol/l

2.90

(3047181) Lactate [Moles/volume] in Blood

559

1.19

0.78

4.7

2.1

1.58

1.24

mmol/l

1.56

471

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

198

0.68

0.78

1.9

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.80

0.77

1.0

1.1

—

31.60

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.72

0.77

1.0

1.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.22

0.77

1.2

1.1

7.00

8.81

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.22

0.77

1.2

1.1

36.70

35.91

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.22

0.77

1.2

1.1

20.10

21.92

—

(3025130) Human papilloma virus identified in Specimen

657

0.83

0.75

1.5

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

139

1033

1.13

0.75

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

139

1035

1.13

0.73

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.01

0.72

1.0

1.4

149.80

345.54

nmol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.01

0.72

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.65

0.68

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

521

0.82

0.68

3.8

5.7

41.63

117.68

u/ml

1.71

185

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

261

1.26

0.67

1.3

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.64

0.62

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

519

1.17

0.62

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.53

0.59

1.1

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

237

1.24

0.57

1.3

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

462

1.17

0.56

1.2

5.11

3.34

u/ml

0.24

186

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.63

0.55

1.5

1.3

1.23

1.83

mg/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.40

0.54

1.3

1.6

—

(40763590) HLA-DQ beta [Type]

1.58

0.54

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.58

0.54

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.53

0.53

1.5

2.4

—

(3022229) Phosphate [Moles/volume] in Urine

1.44

0.50

2.3

3.1

18.02

19.86

mmol/l

0.19

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.47

0.50

1.0

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

523

1.14

0.50

1.7

2.3

32.51

33.33

0.78

523

(1617658) Protocol used for examination of sentinel lymph nodes

564

0.87

0.49

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.63

0.48

1.7

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

527

0.86

0.48

1.4

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.48

0.46

1.1

—

(4281824) Cell count and differential, peritoneal fluid

694

1.12

0.46

1.3

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

231

1.20

0.43

4.1

2.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.62

0.43

1.4

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

1.20

0.41

1.5

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

211

1.20

0.39

1.1

1168.57

1462.99

miu/ml

0.95

211

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

349

2807

1.05

0.37

3.3

4.2

35.39

48.73

u/ml

1.58

333

2728

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.66

0.36

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

459

1.12

0.35

1.2

28.08

5.57

u/ml

0.50

159

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.37

0.34

5.0

3.9

—

0.00

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.37

0.34

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

287

0.85

0.34

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

483

0.89

0.33

1.2

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.68

0.33

1.7

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.28

0.30

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.23

0.29

1.3

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

141

1.19

0.27

1.7

2.4

96.84

165.09

ng/l

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.70

0.26

2.8

3.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.27

0.24

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.72

0.24

1.3

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.70

0.24

1.0

—

(3010421) pH of Blood

102

806

1.07

0.24

8.4

2.7

7.41

7.42

1.78

758

(40760410) HLA-B [Type] by High resolution

1.32

0.23

1.0

—

(40760409) HLA-A [Type] by High resolution

1.32

0.23

1.0

—

(40768795) Lymph node Pathology biopsy report

693

1.07

0.23

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.74

0.22

1.1

—

(3013862) HLA-DP [Type]

1.24

0.22

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.6

—

414.78

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.19

3.2

2.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

0.82

0.19

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.15

0.19

1.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

611

1.06

0.18

4.1

3.7

26.30

51.47

u/ml

2.24

604

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.18

0.16

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.10

0.16

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.10

0.16

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

215

1.10

0.14

1.7

2.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1491

12656

0.99

0.12

3.1

2.9

—

(40761535) Cells panel - Urine sediment

480

4096

0.99

0.10

3.4

2.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.10

0.09

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.12

0.08

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.83

0.08

2.4

2.9

15.58

23.08

mg/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.07

0.08

1.6

2.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

140

1.08

0.07

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.84

0.07

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

256

1.05

0.07

1.3

1.5

6.15

8.47

ug/l

0.29

179

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

680

5708

1.00

0.02

1.5

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

412

0.98

0.02

1.1

1.27

2.46

u/ml

0.37

135

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

132

0.96

0.01

1.2

43.67

65.24

u/ml

0.84

126

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

250

0.98

0.01

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

323

1.02

0.00

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

283

0.98

0.00

1.7

1.3

—

(3012501) Base excess in Blood by calculation

694

1.01

0.00

9.1

2.6

3.09

2.40

mmol/l

1.58

468

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

139

0.97

0.00

2.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

171

0.98

0.00

1.0

—

(40768793) Breast Pathology biopsy report

168

1410

1.00

0.00

1.4

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

139

1.03

0.00

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.94

0.00

1.7

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

3.9

—

1.06

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

12.91

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.88

-0.00

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.86

-0.00

1.4

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.86

-0.00

2.4

2.9

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

40.14

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.97

-0.00

2.9

1.9

0.57

0.51

u/field

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

1.53

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint CPAP and mortality.

Females

Parameter	HR [95% CI]	p-value
CPAP	3.242 [2.82, 3.73]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.398

During the follow-up period (1.1.1998 — 31.12.2019), 3807 out of 20443 females with CPAP died.

Males

Parameter	HR [95% CI]	p-value
CPAP	2.609 [2.26, 3.01]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5627 out of 33117 males with CPAP died.

Mortality risk

Mortality risk for people of age

years, who have CPAP.

N-year risk	Females	Males
1	0.307%	0.48%
5	2.055%	2.949%
10	4.78%	7.29%
15	9.292%	13.455%
20	15.925%	22.439%

Relationships between endpoints

↥

Index endpoint: CPAP – Continuous positive airway pressure

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Continuous positive airway pressure

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints